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An ultra high performance supercritical fluid chromatography-tandem mass spectrometry 
(UHPSFC-MS/MS) method was developed and validated for the determination of a group of 
basic drugs of abuse in human whole blood. The following compounds were evaluated for the 
applicability for this technique: 2-, 3-, and 4-fluoroamphetamine, 2-, 3-, and 4-
fluoromethamphetamine, 2-, 3-, and 4-methylmethcathinone, 2-, 3- and 4-
methylamphetamine, amphetamine, methamphetamine and 3,4-
methylenedioxymethamphetamine. For the validation of the method the following compounds 
were included: 2-, 3-, and 4-fluoroamphetamine, 2-, 3-, and 4-fluoromethamphetamine, 
amphetamine, methamphetamine and MDMA. The sample preparation consisted of liquid-
liquid extraction using ethyl acetate : heptane (80:20, v/v). The samples were reconstituted in 
isopropanol before injection. Four 
13
C6-labelled analogs were used as internal standards. The 
compounds were separated using an ethylene-bridged hybrid column (3 mm x 100 mm, 1.7 
µm) by gradient elution with 40 mM ammonia in methanol and supercritical carbon dioxide.. 
Quantification was performed by tandem MS using multiple reaction monitoring in positive 
mode, applying two transitions for the compounds and the internal standards. The run time for 
the method was 4 min. The calibration curves had r
2
 above 0.99 for all the compounds.The 
interday precision was below 15 % for all the 2-, 3-, 4-phenethylamine analytes for the levels 
above lowest limit of quantification (LOQ), while the classical phenethylamines displayed a 
precision below 10 % for the levels above LOQ. The intermediate accuracy was below 20 % 
for all the 2-, 3-, 4-phenethylamine analytes for the levels above LOQ, while the classical 
phenethylamines demonstrated accuracy below 10 % at all levels. However, the accuracy 
diverged less than 3 % for most of these levels. LOD varied from 0.007 to 0.02 µM, while 
LOQ ranged from 0.02 to 0.06 µM for all analytes. Matrix effects were between 67 and 81 % 
for all the 2-, 3-, 4-isomers, while the classical phenethylamines experienced between 88 and 
93 % matrix effect. Extraction recovery was above 80 % for the 2-, 3-, 4-isomers, though the 
classical phenethylamines had a minimum of 50 % extraction recovery. Carry-over was 
measured to range between 0.34 and 0.88 % for all analytes. Intraday precision was below 15 
% for all analytes, while the intraday accuracy was +/- 20 % for all analytes above LOQ. It 
was noted that for the conditions of this method chromatographic separation was decreased 
with repeated injections, proposedly caused by a silyl ether formation or alcohol adsorption 
on the stationary phase. Additionally, a spray pulsing effect was observed in the UHPSFC-MS 
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µ  Greek letter mu, abbreviation for micro (10
-6
)  
µL  microliter 
µM  micromolar 
mg  milligram 
mM  millimolar 
σ  Greek letter sigma, symbol for standard deviation 
atm  Atmospheric  
ADHD Attention deficit hyperactivity disorder 
BPR  Back pressure regulation 
CO2  Carbon dioxide 
CSP  Chiral stationary phase 
EMCDDA European Monitoring Centre for Drugs and Drug Addiction 
ESI  Electrospray ionization 
ESI+  Electrospray ionization, positive ion scanning 
GC  Gas chromatography 
KRIPOS National Criminal Intelligence Service 
LC  Liquid chromatography 
MDMA 3,4-methylenedioxymethamphetamine 
MMC  Methylmethcathinone 
MRM  Multiple reaction monitoring 
MS  Mass spectrometry 
MS/MS Tandem mass spectrometry 
NH3  Ammonia 
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NIPH   Norwegian Institute of Public Health  
NMBU Norwegian University of Life Sciences   
NPS  New psychoactive substances 
ODS  Octadecylsilane 
P  Pressure 
Pc  Critical pressure 
PMA  Parametoxyamphetamine 
PMK  Piperonyl methyl ketone 
PMMA  Parametoxymethamphetamine (1-(4-methoxyphenyl)-2-methylaminopropane) 
RSD   Relative standard deviation 
SD  Standard Deviation 
SIRUS  Norwegian Institute for Alcohol and Drug Research 
SFC  Supercritical fluid chromatography 
SPE  Solid phase extraction 
SSB  Statistics Norway 
T  Temperature 
Tc  Critical temperature 
TAAR1 Trace amine-associated receptor 1 
UHPLC Ultra high performance liquid chromatography 
UHPSFC Ultra high performance supercritical fluid chromatography 
UN  United Nations 
UNODC United Nations Office on Drugs and Crime 
UPC
2
  Ultra Performance Convergence Chromatography 





1.1.1 New psychoactive substances 
 
New psychoactive substances (NPS) are a range of chemical compounds produced as 
substitutes for classical drugs of abuse. They are often referred to as “legal highs”, referring to 
their initial lack of legislation. Although referred to as new psychoactive substances, many of 
these substances have been developed as medicinal drugs, but put aside due to harmful side-
effects or lack of desired pharmacological effect. Despite this, compounds are being revived 
by clandestine drug producers lacking the concern of prior data suggesting high toxicity. 
There are several subclasses of NPS, of which phenethylamines and synthetic cathinones are 
among the largest.  
Traditionally, the most common phenethylamines; amphetamine, methamphetamine and 
MDMA, have been consumed as recreational drugs by young consumers or by outlaw motor 
cycle gangs (Sanders, 2005; Armstong, 2007). However, the profile of the “typical” 
consumers seems to have evolved in recent years, as phenethylamines are found to act as a 
performance-enhancer among athletes, laborers in hard and tedious work, students, party-
goers and in older polydrug abusers (WHO). A recent Norwegian study distinguished between 
three groups of consumers; the party-goers, the hard-workers and the people suffering from 
ADHD, depression or fatigue who self-diagnose and self-medicate (Pedersen et al., 2015). 
This is consistent with the findings of another recent study, where the substance was revealed 
as the most prevalent among incarcerated users. Two underlying causes were highlighted in 
the study; psychological trauma and ADHD (Shammas et al., 2014). Many of the inmates in 
the study of Pedersen et al. claimed to suffer from ADHD (2015) and a recent study suggested 
that more than half the prison population in several European and North-American countries 
might be suffering from this disorder (Young et al., 2011). 
The market for narcotics appears to have evolved towards being more changeable and 
dynamic than in previous years. The market is in lesser extent concentrated around using 
plant-based drugs like cocaine and heroin, but rather on using synthetic substances, which 
makes it possible to produce the illicit drugs closer to the consumers (EMCDDA 2010-2015; 
Folkehelserapporten 2014; KRIPOS 2015; SIRUS 2010-2015; UNODC, 2014). Instead of 
smuggling the illegal drugs across distances and borders, drug precursors can legally be 
transported across borders. Precursors of many drugs are legal as they are used for several 
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purposes, as for the precursors of amphetamine and MDMA which can also be used in the 
synthesis of perfume, pesticides, insecticide, medicine and other chemical products (Reade, 
2010).  This eliminates the risk of hazardous long distance transport, smuggling across 
borders and harsh criminal penalties. Additionally, the internet facilitates rapid distribution 
between clandestine drug producers and consumers. The internet thus functions as a global 
market place, where drugs can be bought anonymously and sent in discrete, unmarked 
packages by mail (EMCDDA, 2015). 
There is thus an ongoing cat-and-mouse game between legislators and drug suppliers. Drug 
suppliers react rapidly to legal measures like prohibition, resulting in substance replacement, 
producing a new modified version of the classical ones. This rapid evolvement of drugs on the 
market is challenging for forensic toxicologists, demanding relentless evolvement of new 
analytical methods to unveil new substances of abuse.  
 
1.1.2 Forensic toxicology at the Norwegian Institute of Public Health 
 
This thesis work was performed at NIPH, Domain for Forensic Sciences at the Department of 
Drug Abuse Research. The Department is divided into two subdivisions; Drug Abuse 
Research and Method Development. The group of method development conducts analytical 
toxicological research, focusing on development and validation of new methods for drug 
analysis in blood, urine, saliva, hair and dialysate.  
The purpose of the domain of Forensic Science is to provide science-based, biomedical 
knowledge on an international level for use by the judiciary and service to the community. 
The Department of Drug Abuse Research and Method Development collaborates with the 
Department of Drug Analysis and the Department of Toxicological Analysis, which annually 
receives on average more than 30 000 forensic samples from the police, the judiciary, the 
Norwegian Correctional Services, the Norwegian Labor and Welfare Service, social and child 
welfare services, private companies and the health service. Data of samples received at NIPH 




1.2 Aims of thesis  
 
The aim of this thesis work was to develop and validate a method which could separate and 
distinguish a group of new synthetic amphetamines and their constitutional isomers by a 
UHPSFC-MS/MS method. The following substances where included: 2-, 3-, 4-
fluoroamphetamine, 2-, 3-, 4-fluoromethamphetamine, 2-, 3-, 4-methylmethcathinone, 2-, 3-, 
4-methylamphetamine, amphetamine, methamphetamine and MDMA. 
The road to a finished developed method utilizing UHPSFC-MS/MS for analysis of the 
constitutional isomers of the analytes of interest entailed a series of partial goals. Foremost a 
method capable of separating the analytes was needed and a subsequent optimization. The 
extraction method would need to be satisfactory for extraction of the analytes from whole 
blood. For the method to be used in the routine laboratory of the NIPH, a method validation 




Figure 3. Advertising campaign promoting the use of 
amphetamine as an antidepressant and diet pill (theawl.com). 
2. Theory 
2.1 New psychoactive substances   
– Phenethylamines and synthetic cathinones 
2.1.1 Culture of phenylethylamine and cathinone abuse 
 
Phenethylamines are a group of substances characterized by its resemblance to the natural 
monoamine alkaloid phenethylamine (Figure 1). Phenethylamines are classified as stimulants, 
entactogens
1
 or psychoactive hallucinogens by their pharmacological properties, and includes 
substances like amphetamine, methamphetamine and 3,4-methylenedioxymethamphetamine 






Cathinones are also a group of monoamine alkaloids, but differs from the phenethylamines in 
having a ketone functional group in its common structure (Figure 2). These substances share 
both structural and pharmacological similarities with the phenylethylamines, and include both 
natural and synthetic compounds like cathinone from khat, 
ephedrine and 4-methylmethcathinone, better known as 
mephedrone. 
Psychoactive hallucinogens are known to induce psychosis, 
but unlike cathinones, they are thought to produce less 
dependence (Nichols, 2004). Phenylethylamines that have 
direct and indirect serotonergic agonist properties are 
associated with more entactogenic effects than cathinones 
(Tyrkkö et al., 2015). 
  
                                                          
1
 Entactogen is a term used to describe drugs that produce experiences of empathy and induce feelings associated 
thereof; emotional communion, oneness, relatedness, emotional openness. 
Figure 2. Base structure of cathinone 
(made at emolecules.com). 
Figure 1. Base structure of phenethylamine 
(made at emolcules.com). 
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Amphetamine was first synthesized in China in 1887, while methamphetamine was first 
synthesized in Japan in 1914. Production of amphetamine as a synthetic drug was first 
performed in 1887, but did not gain much interest until its stimulatory effects were discovered 
in the beginning of the 20
th
 century by biochemist Gordon Alles (Cody, 2005). The 
stimulatory effects of amphetamines were extensively exploited during World War II. Allied 
forces were supplied amphetamine pills known under its brand name Benzedrine, while Axis 
and Japanese forces provided their soldiers with Pervitin, pills made from the slightly stronger 
substance methamphetamine. However, amphetamines were also strongly marketed for the 
general population. Marketing campaigns from the pharmaceutical industry promoted 
amphetamines as antidepressant and diet pills (Figure 3 and 4). Although uncertain efficacy 
and safety of amphetamines, therapeutic and recreational use increased immensely until the 
1960s and was prevalent in everyday life in many countries. However, as the addictive and 
harmful effects became elucidated, stricter regulations were implemented and amphetamines 
became prescription drugs (Rasmussen, 2008).  
 
Figure 4. Advertisement for amphetamine pills in the US, known under its market name Benzedrine (Rasmussen, 2008; 
California Western Medicine, April 1945) 
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What is bought on the street is most often made in clandestine laboratories. The synthesis 
results in a product with impurities like reactants, unwanted by-products and stimulant by-
products, like amphetamine residues in a methamphetamine synthesis, and always consists of 
a mixture of drug and various other compounds. The doses are additionally “diluted” with 
caffeine, sugar, salts etc. to enable more profit per dose for the distributors. Besides, the 
manufacture results in a racemic mixture, where one of the enantiomers of amphetamine, 
dextroamphetamine, is more potent as a stimulant euphoriant, as it is a more potent agonist of 
the trace amine-associated receptor 1 (TAAR1) than levoamphetamine (Lewin et al., 2011). 
Consequently, dextroamphetamine produces greater central nervous system stimulation than 
levoamphetamine, roughly three to four times more, but levoamphetamine has slightly 
stronger cardiovascular and peripheral effects (Vaughan and Foster, 2013). Thus, both the 
composition and chirality profile indicates the link between the starting materials and the 
illicit drug synthesized by the clandestine chemist. 
Another common phenethylamine is MDMA, which is often considered the drug of choice 
within the rave culture and is also used at clubs, festivals and house parties (Carvalho et al., 
2012). The prevalence of MDMA experienced a peak in the 1990s and increased until year 
2000, after which it stabilized (EMCDDA, 2003). In 2008-2009 a sharp decrease in the 
occurrence of MDMA on European markets was likely caused by successful law enforcement 
actions and an international cooperation between Europe and Asia by targeting the main 
precursor of MDMA, piperonyl methyl ketone (PMK). The market was partially reimbursed 
with MDMA in 2010, indicating that clandestine manufacturers found alternative precursor 
chemicals. Several production facilities revealed in the Netherlands and Belgium in 2013 and 
2014 seems to confirm this (EMCDDA, 2015ii). Nevertheless, the temporary MDMA 
shortage led suppliers to adapt by selling other synthetic substances as MDMA (Glennon, 
2014). This resulted in several fatal intoxications across Europe, where the victims 
supposedly had taken MDMA or similar substances (Dybdal-Hargreaves et al., 2013). Several 
seizures and forensic autopsies revealed the occurrence of several novel NPS in recent years. 
One of the more prominent was parametoxymethamphetamine, in which resulted in a total of 
27 deaths in Norway in the period of 2010-2012 (Vevelstad et al., 2012; Al-Samarraie et al., 
2015).   
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NPS are referred to as legal highs, research chemicals, plant food, bath salts etc. and they are 
often marked “not for human consumption” in order for the suppliers to avoid regulatory 
control and customs. The increasing selection and abuse of NPS has experienced a rapid 
growth, which could only have been possible through the internet and various other virtual 
social networks. A selection of the available NPS’s are shown in Figure 5. There are still vast 
majorities in making new chemical compounds with slight modifications and each year there 
is a selection of 
novel substances 
appearing on the 
market (KRIPOS, 
2014). 
Figure 5. A variety of NPS 
seized by KRIPOS (KRIPOS, 
2015). 
 
2.1.2 Prevalence of the new psychoactive substances in Norway 
 
The first fatal NPS incidence was reported in Norway in 2003; intake of pills thought to be 
ecstasy, was found to be a combination of paramethoxyamphetamine and 
paramethoxymethamphetamine (Refstad, 2003). Since then, there has been an increase in the 
Norwegian market from a limited selection of alternatives to the classical drugs to a wide 
selection of 101 different substances in 2014 (Figure 6). The increasing number of seizures of 
NPS in Norway is consistent with the overall European findings by the EMCDDA and UN 
World Drug Report 2015, as UNODC reported an increase in the NPS selection, peaking at a 
total of 450 different NPS on the European market in 2014 (UNODC, 2015).In Norway, a 
total of 620 seizures of NPS were made in 2014 by KRIPOS, shown in Figure 6, and 20 100 
people were charged for a total of 40 300 drug offenses. Data from the Norwegian customs 
laboratory also show that the variety of NPS confiscated have been ever increasing the last 
few years and less than 10 % of the NPS packages confiscated contained of NPSs listed in the 
Norwegian drug list. This suggests that consumers know how to circumvent current 
legislation, while the market is changing in response to new regulations (Skjørsæter, personal 
correspondence). Men are overrepresented in the statistics of abuse and possession of 




Figure 6. Graph showing the increase in NPS in Norway. Adapted from the webpage of SIRUS. 
Trade and consumption of NPS is challenging to discover as the internet facilitates 
anonymous global trading of drugs, functioning as a cryptomarket often using 
cryptocurrencies like bitcoins (EMCDDA, 2015iii). In order to elucidate the extent of NPS 
abuse in Norway, a nightlife study was conducted in collaboration between Statistics Norway 
(SSB) and NIPH in 2014. The survey aimed to uncover the prevalence of drug abuse in Oslo’s 
nightlife among 1 100 young people, aged 18-35. The study was conducted by voluntary and 
anonymous participation of nightlife patrons and sample collection was performed by an oral 
fluid sampling device. The results showed 1.4 % tested positive for an NPS during sample 
collection and that 7 % of the responders replied to have ever tried an NPS (Gjerde et al., 
2016). In 2013, a school survey was conducted in the district of Ullern in Oslo, where 425 
children in the age span of 14 to 16 years of age participated. 3.1 % replied to have tried an 
NPS at some point, while 6.3 % had been offered an NPS (SIRUS webpage, 2013). These 
Norwegian findings are consistent with the findings by the 2014 Flash Eurobarometer, a 
survey of 13 000 young adults aged 15-24 in the EU member states. 8 % of the respondents 




2.1.3 Legislation concerning new psychoactive substances in Norway 
 
The Norwegian legislation on drugs is covered by the narcotics legislation and the medicinal 
drugs act. In February 2013, a set of new drug regulations were adopted in Norway in an 
attempt to mitigate the increase of NPSs. These substances were produced as an alternative to 
classical drugs of abuse in an attempt to avoid current legislation.  Their structure and 
physiological function resemble their illegal cousins, but by modifying one or a few atoms of 
the original substance, clandestine chemists were able to produce drugs which at first were not 
enforced by any law. This drug regulation defines drugs more precisely than previous and 
includes a list of illicit drugs, currently including ten groups of substances, phenethylamines 
and cathinones being two of them. 
For a substance to be classified as a drug of abuse several criteria must be obeyed. The 
compound must have a psychoactive effect, be harmful and addictive. It must additionally 
cause tolerance and abstinence, and have a scattering potential (Narcotics legislation; 
Skretting, 1999). The Norwegian Medicines Agency (Norwegian: legemiddelverket) decides 
what substances are defined as narcotics. The NPS of this thesis became illegal in Norway in 
2013. However, the legislation of 2013 included a range of new substances and their salts, 
stereoisomers, esters and ethers of the groups listed are also included, but still left a need for 
new legislation each time a new, slightly modified substance appears on the market (Narcotics 
legislation, Medicinal drugs act). 
According to the Norwegian Medicines Agency, 10 of the 23 new substances identified in 
2014, were included in the new drug legislation from 2013 by belonging to a group of similar 
substances, by so-called generic listing. In order for the remainder of these compounds to be 
scheduled, a listings proposal must be submitted for evaluation. In the meantime, they are 
covered by the medicinal drugs act, and consequently must obey its regulations on import, 




2.2 Sample matrices  
 
In contemporary forensic toxicological analysis, there is a range of possible sample matrices. 
Drug analysis of blood, urine, hair, and oral fluid has been successfully implemented with 
liquid chromatography (LC), in which all are represented in the analysis repertoire at NIPH. 
Whole blood and urine are the most common biological fluids used for drug confirmation and 
quantification (Chèze et al., 2007; Marin et al., 2008; Øiestad et al., 2007; Gergov et al., 
2009; Øiestad et al., 2011; Montesano et al., 2014). 
Urine contains both the drugs taken and its metabolites, but does not indicate current 
impairment, as drug concentration in urine does not immediately increase after intake. 
Therefore drug testing is most commonly used for determination of abuse and not of 
impairment, e.g. in traffic incidents. Drug detection in urine has the advantage of being 
relative non-invasive compared to blood withdrawal, but requires that the specimen collection 
must be done under surveillance of authorized personnel. Urine has a longer detection 
window compared to blood, up to several days after intake, and is mainly applied for 
workplace drug testing, drug testing of prisoners, drug abuse rehabilitation programs or 
clinical drug screenings (Gjerde et al., 2011). 
For most drug analytes, blood concentration decreases quite rapidly after intake, and blood 
sample collection is invasive and requires medical personnel. Nevertheless, blood is most 
often the specimen of choice when measuring, quantifying and interpreting concentration of 
drugs and correlating metabolites, as it shows the best correlation between drug concentration 
and pharmacologic effects. This can be attributed to blood being the only biological specimen, 
except for cerebrospinal fluid, that reflects drug concentration in the brain (Gjerde et al., 
2011). Blood can produce an immediate approximation of the level of drug thereby 
facilitating the use of cut-off values for later confirmatory analysis, i.e. avoiding too many 
false positives (Skopp, 2004; Birkler et al., 2012; Langel et al., 2014).  
Analysis of blood samples requires extensive knowledge about the composition, properties 
and functions of the blood. Whole blood is a complex mixture of solubilized proteins, 
dissolved fats, solids and suspended cells (Chargaff and West, 1946; Wolf, 1967; Skopp, 
2004; Manzone et al., 2007). The main cell types of blood are red blood cells (erythrocytes), 
white blood cells (leukocytes) and blood platelets (thrombocytes). Red blood cells constitute 
more than 90 % of the total cell number and are the main cause of the relatively high viscosity 
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of the blood. The blood cells are normally distributed in the extracellular fluid plasma, due to 
the continuous motion of the blood. However, the blood cells immediately sink in stagnant 
plasma, due to greater mass density. Furthermore, blood produces three layers when 
centrifuged for the same reasons as shown in Figure 7.  
 
Figure 7. The components and relative proportions of blood (Manzone et al., 2007) 
Many matrix components are thus present in blood to cause interference with the response in 
MS. Serum proteins can reduce sensitivity by binding to analytes, endogenous phospholipids 
can cause significant matrix effects (MEs) and anticoagulants added to blood to prevent 




2.3 Sample preparation of forensic samples 
 
The choice of sample preparation technique is critical for the analysis, as it is error-prone and 
inherently the most labor-intensive part of the analytical process. Ideally, the process should 
be simple, rapid, remove possible interfering compounds, give high recovery, and concentrate 
anayte(s) of interest. 
In order to perform a robust and efficient chromatographic and mass spectrometric analysis of 
biological samples it is important to get rid of possible contaminants and also to retain as high 
a percentage of analyte as possible. All biological samples contain a complex mixture of 
substances. For the method in question blood was chosen as sample agent. Among the most 
prominent contaminants in blood is phospholipids, which is the main component of cell 
membranes and are ubiquitous in blood samples. Phospholipid removal was considered to be 
an important evaluation point when considering different extraction methods, as 
phospholipids are considered to be one of the most troublesome components of bioanalytical 
samples when performing chromatography coupled to tandem mass spectrometry to avoid 
smudging and contaminating the MS (Wu et al., 2008). A possible co-elution could possibly 
result in ion-suppression  or enhancement effects of the MS signal that would cause 
variability and disrupt the accuracy of the methods result.  
 
2.3.1 Liquid-liquid extraction  
 
Liquid-liquid extraction (LLE) is an abstraction of an analyte from one liquid phase to another 
liquid phase (a two-phase distribution of a solute), usually from an aqueous solution to an 
organic solvent. The mechanism underlying LLE is based on transferring the analyte from 
matrix compounds to an appropriate liquid phase based on their relative solubilities in two 
different immiscible liquids.  
 
2.3.2 Solid phase extraction  
 
Solid phase extraction (SPE) is a mechanism based on the analyte binding with great affinity 
to a sorbent solid phase. The ability of the analyte to bind to the solid phase makes it quite 
easy to extract it from the sample matrix. The method procedure requires several steps; 
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conditioning, loading of sample, washing and elution of analytes. When the analyte binds 
with higher affinity to the sorbent then the matrix components, it is possible to wash the 
sorbent to exclude unwanted compounds which have less affinity for the sorbent. The analyte 
can be eluted from the sorbent by using an elution solvent and collected for analysis.  
 
2.3.3 Protein precipitation 
 
A simple sample preparation approach for biological fluid is protein removal by protein 
precipitation. Protein denaturation can be performed using acids, heat, ultrafiltration 
membranes, or by using organic solvents. Protein precipitation partly removes phospholipids 
present in the plasma and serum of blood, depending on the organic solvent used. Studies 
have shown that methanol extracts contain 40 % more phospholipids compared to acetonitrile 




2.4 Chromatography  
– From chromatographic ABC to SFC 
 
2.4.1 Chromatographic ABC  
 
Chromatography is a collective term used to describe a physical method applied for analyte 
separation in mixtures where the components to be separated are distributed between two 
phases; the stationary and mobile phase. A successful chromatographic separation occurs as a 
result of repeated sorption and desorption acting during the movement of the sample 
components along the stationary bed, and the separation is due to differences in the 
distribution constants of the individual sample components. 
The Russian botanist Mikhail Tswett is generally credited for the first development of 
chromatography around year 1900. Using a column of calcium carbonate, he successfully 
separated green leaf pigments like chlorophyll, carotenes, and xanthophylls. The name of the 
technique given by Tswett literally means “color writing”, referring to the initial components 
analyzed, which due to their different colors created colorful bands (Tswett, 1906).                                       
For LC and SFC, the stationary phase used is generally a porous, granular powder in the form 
of a dense homogenous bed packed into a tube, referred to as a column, able to withstand the 
operating pressures normally employed. The sorbents are usually porous solids of high 
surface area, a similar solid modified by bonding a ligand to its surface or used as a support 
for a thin film of liquid, or an inert sorbent on a controlled pore size (packed column). 
Alternatively, the stationary phase can be distributed as a thin film or layer on the wall of an 
open tube of capillary dimensions leaving an open passageway through the center of the 
column. In order to elute the substances of interest a solvent is added to the mobile phase 
referred to act as a displacer. The displacer must have a higher affinity for the stationary phase 
than the sample. The displacer drives the adsorbed components progressively along the 
column, each component displacing the one in front, until they are eluted in the same order in 
which they adsorbed on the column; the least strongly retained being eluted first. 
The chromatographic process provides information summarized in a chromatogram, a record 
of the concentration or mass profile of the sample components as a function of the movement 
of the mobile phase. Information can readily be extracted from the chromatogram, which 
includes an indication of sample complexity based on the number of observed peaks, 
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qualitative identification of sample components based on the accurate determination of peak 
position, quantitative assessment of the relative concentration or amount of each peak, and an 
indication of column performance.  
In chromatography, the term theoretical plate is commonly used as a measure of efficiency in 
a separation process. The term describes a hypothetical stage in which two phases establishes 
an equilibrium with each other, also referred to as an ideal stage, theoretical stage or 
equilibrium stage. Separating substances in a chromatographic process thus depends on series 
of equilibrium stages, where an increased number of theoretical plates mean increased 
efficiency. In the same way theoretical plates arises from the concept of equilibrium stages, as 
does plate height. Plate height is numerically equal to the absorption bed length divided by the 
number of theoretical plates in the absorption bed and is inversely proportional to plate 
number (Poole and Poole, 1991). 
As an extension of these terms, the van Deemter equation (eq. 1) describes the plot of a 
theoretical plate as a function of mobile phase velocity (van Deemter et al. 1956) for packed 
columns. The equation describes three factors of band broadening; eddy diffusion, 
longitudinal diffusion and resistance to mass transfer. The equation is a hyperbolic function 
that predicts the optimum velocity (Figure 8). 
 
              
     
  
        
             
  
    eq.12 
                                                          
2
 H = Plate height, λ = packing factor, dp = particle diameter, γ =obstruction factor, u =mobile phase linear 




Figure 8. Van Deemter plot showing the contributions from the different terms of the van Deemter equation 
(Chromacademy). 
 
The Basics of Supercritical Fluid Chromatography 
 
Supercritical fluid chromatography (SFC) is a chromatographic technique using supercritical 
or subcritical fluid as a mobile phase, referring to the conditions of the fluid being above or 
just below the critical point, respectively. The technique is used for the analysis and 
purification of most low to moderate size molecules, and even thermally labile molecules. 
One of the most successful applications of supercritical fluid chromatography has been the 
separation of enantiomers on chiral stationary phases (CSP) (Khater et al., 2013a; Lee et al., 
2014). Properties making SFC favourable for chiral separations include lower operating 
temperatures compared to GC, higher diffusivity of the solutes and reduced viscosity of the 
eluent compared to traditional LC. Lower operating temperatures reduces the probability of 
racemization of either the analyte or the CSP, eliminating the need for a derivatization agent 
during sample preparation and often resulting in improved enantioselectivity (Petersson et al., 
1994). Higher diffusivity of the solutes and reduced viscosity of the eluent offers higher 
efficiency and shorter analysis time compared to LC.  
The principles of SFC are similar to those of LC, differing in the use of carbon dioxide (CO2) 
as the mobile phase. For proper solvation of the analytes in the mobile phase, an organic 
solvent is used as a solvent and a displacer. In SFC, the solvent is referred to as a modifier, a 
term which is specific to SFC. SFC holds several theoretical advantages, such as low 
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viscosity, high density and elevated analyte diffusion coefficient. These properties enables 
fast analysis at high linear velocity and higher chromatographic resolution can easily be 
achieved in SFC with long columns compared to LC, whilst keeping the column-pressure 
drop at a reasonable level (Kaczmarski et al., 2012; Grand-Guillaume Perrenoud et al., 2014; 
Poe et al., 2014; Lesellier et al., 2014b). In recent years instrumentation with sub-2-µm 
particles have been attainable for SFC applications as well, often referred to as UHPSFC, 
which further enhances the potential kinetic performance of SFC as shown in Figure 9  
(Lesellier et al., 2011; Khater et al., 2013b; Biba et al., 2014; Grand-Guillaume Perrenoud et 
al., 2014).  
 
Figure 9. Kinetic performance expressed in van Deemter curves for butylparaben for UHPLC and UHPSFC systems 
equipped with 1.7 and 3.5 µm particles (adapted from Grand-Guillaume Perrenoud et al., 2012b). 
 
2.4.2 History of supercritical fluid chromatography 
 
A supercritical fluid is an element or a compound above its critical point, the critical point 
being defined by its critical temperature and pressure (Figure 10), where there is no change in 
state as pressure is increased or heat is added (Klesper, 1978; Fountain et al., 2014). It is a 
misleading name, in that it implies enhanced properties.   
The critical point was identified in 1822 by Baron Charles Cagniard de la Tour, while 
conducting experiments involving the discontinuities of the sound of a flint ball in a sealed 
cannon barrel filled with various fluids at various temperatures. De la Tour was able to 
observe a reduction to vapor in a space from two to four times the original volume of the 
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sample (de la Tour, 1822 and 1823). Nevertheless, the nature of the transition was not 
understood until 1869 when Andrews performed quantitative measurements on CO2. The term 
“critical point” was first applied by Andrews to describe the phenomenon associated with the 















Figure 10. Phase diagram showing the critical point and progression towards subcritical and supercritical properties 
(adapted from Wikipedia and modified in Paint).  
The properties of elements or compounds beyond the critical point were however not 
considered for many years. Supercritical fluids remained a curiosity and were not considered 
to have an analytical potential until Jim Lovelock proposed a chromatography method, at a 
GC conference in 1957, utilizing supercritical fluid as a mobile phase. He suggested the name 
“critical state chromatography”. SFC was first performed by Klesper et al. in 1962 (Klesper et 
al., 1962; Guiochon and Tarafder, 2011), and subsequently they reported a new SFC system 
equipped with a mechanical back pressure regulator that could control the pressure 
independent of the flow rate (Saito, 2013). Karayannis and Corwin showed in 1968 how to 
independently control the column back pressure and the flow rate and described a UV 
detector with a cell operating under high pressure (Karayannis et al., 1968). During the same 
time period Sie and colleagues published a series of articles on what they referred to as high-
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pressure gas chromatography (HPGC) with supercritical CO2 as the mobile phase. The articles 
discussed fluid-solid and fluid-fluid separation modes (Sie and Rijnders, 1967). In 1969, 
Giddings and colleagues emphasized the importance of carrying out gas chromatographic 
separation under extremely high pressures, up to 2000 atm (which they called dense gas 
chromatography), and implied a possible convergence with classical LC, many years before 
the title unified chromatography was identified and reported by Ishii et al. (1988) and more 
recently by Chester and Pinkston (1998). Gouw and Jenthoft (1970) developed a pressure-
programmed SFC, applied to separate a wide molecular weight range samples of polynuclear 
aromatic hydrocarbons and of styrene oligomers. The instruments for SFC were not as 
sophisticated and advanced as those for HPLC. Yet, the latter took over in the late 1970s 
while the former remained a niche mode of chromatography until today/to this day. Klesper 
and Hartmann developed preparative SFC and used it to purify oligomers of styrene, which 
they also analyzed by mass spectrometry (Klesper and Hartmann, 1978). However, SFC was 
not recognized as a useful method until the 1990s due to the concurrent arrival of HPLC, 
which at the time produced a more versatile and robust analysis (Saito, 2013).  
Currently, CO2 is the most widespread supercritical fluid used in SFC. It displays the 
advantages over other fluids, as shown in Table 1, of having smooth critical conditions of 
temperature and pressure (31°C and 1073 psi) fully compatible with chromatographic 
instrumentation. It is also relatively safe (non-toxic, non-flammable), inert and quite cheap. 
Table 1. Beneficial properties of CO2 as supercritical fluid mobile phase in SFC  
Advantages of using CO2 in SFC: 
 
Easily achievable critical conditions; 31°C and 1073 psi (Grand-Guillaume Perrenoud et al.,  2014) 







Good compatibility with MS 
Low viscosity, thus making it easy to achieve high efficiency 
 
The very high density of the carrier gas at these pressures allows intermolecular forces to 
become very high, permitting the extraction of macromolecules into the gas phase. Giddings 
et al. (1969) used helium, nitrogen, CO2, and NH3 as carrier gases and separated nucleosides, 
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nucleotides, and purines, proteins, peptides and amino acids, sugars, terpenes, and steroids. 
However this work was unfortunately not pursued by the authors. Later research related to 
SFC has been almost exclusively dedicated to CO2 as mobile phase (Guiochon and Tarafder, 
2011). Although other compounds also possess the ability to be in a supercritical state, few 
can compete with CO2 in its range of beneficial properties (Berger, 1997). Additionally, most 
studies have focused solely on pressure and mobile phase density, rather than different 
possible organic modifiers and additives (Blackwell et al., 1999; Brunelli et al., 2008; Fogwill 
and Thurbide, 2008; Kato et al., 2009; Hamman et al., 2013; Lee et al., 2014). For now there 
is still limited knowledge concerning the molecular interactions between solutes, mobile 
phases and stationary phases, but hopefully the burst of interest in this field will lead to new 
insights in near future. 
SFC recent rise in popularity occurred in 2008 after a long period of being a niche method, 
due to an acetonitrile shortage, which forced researchers and engineers to develop alternative 
strategies. SFC was considered a valuable option, because its mobile phase requirements are 
drastically different from those of conventional chromatographic techniques (Nováková et al., 
2014).  
The name SFC is thus often inadequate as the conditions often are below critical value for the 
mobile phase fluid. The term subcritical fluid chromatography is alternatively used, but is 
equally inadequate as a subcritical fluid (with P<Pc and T<Tc) is actually a liquid (Figure 10). 
The controversy surrounding the name of SFC is described in Appendix III. The re-
emergence of SFC the last few years has been possible due to the arrival of equipment that is 
significantly improved. SFC instrumentation slowly evolving over a number of decades in 
combination with the many improvements in LC equipment this century has resulted in well-
designed, highly efficient, highly robust and user-friendly SFC-instrumentation.  
2.4.3 Applications of supercritical fluid chromatography 
 
Klesper and colleagues attempted to separate porphyrin derivatives that could not be analyzed 
by GC because they begin decomposing at temperatures where their vapor pressure is too low 
to allow for elution (Klesper et al., 1962). Today SFC is a more universally applied method 
and it is often orthogonal to the more commonly used UHPLC in pharmaceutical analysis (de 
la Puente et al., 2011; West and Lesellier, 2008a and b; Lemasson et al., 2015b). This is 
crucial in method development as verification of the method should also be done in an 
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instrument with a different technique than the instrument used in the analytic method to verify 
analytical results. 
SFC is considered to be superior for chiral separations (Stringham and Blackwell, 1997; 
Phinney, 2000; Stringham, 2005; Plotka et al., 2014; Lesellier and West, 2015). The potential 
for chiral separations lies in that it is possible to adjust several parameters simultaneously; 
temperature, back pressure, modifier type, gradient, additive type and additive concentration. 
It should be noted that both temperature and back pressure afflict the density of the mobile 
phase fluid.  Fine tuning an SFC method gives more possibilities to adjust the separation, 
producing separation for many analytes which cannot be analyzed with regular LC or GC 
methods. SFC being water-free or nearly water free is an advantage for separating analytes 
that are hygroscopic or which degrade in the presence of water.  
SFC is thus interesting for its analytical applications, but also due to its green profile. 
Compared to other solvents utilized in analytical chemistry, it produces far less adverse 
effects to human health, safety, biodegradability and the environment (Plotka et al., 2013). 
 
2.4.4 Conditions of supercritical fluid chromatography 
 
Few analytes are soluble in the apolar supercritical CO2 alone, so different organic solvents 
are often included. The organic solvent is often referred to as a modifier, when added to the 
SFC mobile phase. Addition of modifier increases the solvating power of the mobile phase for 
better solubility of polar analytes, by increasing the polarity of the mobile phase in SFC 
(Bartmann and Schneider, 1973; Strubinger et al., 1991b; Tarafder, 2016). Polar modifiers 
used in combination with polar stationary phases can produce good resolution and 
symmetrical peaks. The modifier can also affect the retention, by changing the density of the 
mobile phase, but probably has limited effect. Using an alcohol modifier in combination with 
a silica-based column can lead to blockage of active sites on the stationary phase or alcohol 
adsorption onto the surface of the stationary phase over time, leading to alteration of the 
chemical environment the analytes are subject to under chromatographic elution. Adsorbed 
modifier molecules can also lead to a modification in the net volume of the stationary phase, 
which alters the phase ratio of which the analytes are subject to under the chromatographic 
separation (Janssen et al., 1989; Strubinger et al., 1991a and b; Heaton et al., 1994; Gurdale et 
al., 2000; Lesellier et al., 2002; de la Puente et al., 2011; Desfontaine et al., 2015; Fairchild et 
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al., 2015; Lesellier and West, 2015; Tarafder, 2016). When sufficient modifier is added, the 
elution strength increases, resulting in elution of the analyte when the level of the interaction 
between the analyte and the mobile phase is equal to that of the analyte and the stationary 
phase. Different modifiers are compatible with SFC conditions and provide a range of 
possibilities in optimizing the separation of analytes by differing the polarity of the mobile 
phase (Figure 11).  
 
Figure 11. Schematic overview of the polarity ranges of the mobile phase combination in SFC-MS (Kott, 2013).  
Although many possible solvents can be used as modifier in SFC, the most commonly applied 
solvent has so far been methanol. The combination of supercritical CO2 and methanol yields a 
mobile phase with a very nonlinear solvent strength. The empirical P’ scale, originally 
intended for normal phase HPLC, indicates that the addition of only 2 % methanol produces a 
fluid with a polarity expected from 10 % methanol. The phenomenon of enhanced solvent 
strength in SFC is caused by clustering of the polar modifier molecules. This creates pockets 
with a polarity higher than what might be expected. Polar solutes tend to be solvated within 
such clusters (Berger, 2007). 
The conditions are probably subcritical when a sufficient amount of modifier is added, 
producing two distinct phases in the system. This is the result of a much higher critical point 
of the modifier.  The total critical point of the binary mixture can be simplistically estimated 
as the arithmetic mean of the critical temperatures and pressures of the two components, as 
shown in equation 2 and 3: 
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Tc mix = x1Tc,1  + x2Tc,2       (eq. 2) 
Pc mix = x1Pc,1 + x2Pc,2       (eq. 3) 
X is the mole fraction of the respective component, whereas Tc and Pc refers to the critical 
temperature and pressure of the indicated component, respectively. Calculating the arithmetic 
mean only gives approximate results, as it does not take into account the fact that the solvents 
may experience interactions with each other, varying from different types of modifiers. 
Estimating critical point for the binary mixture can be done more accurately by using 
equations of state, e.g. the Lee-Kesler or the Peng-Robinson equations, or by using group 
contribution methods (Poole and Poole, 1991). Saito (2013) estimated the critical temperature 
and pressure of CO2-methanol mixtures, where 5 % methanol in CO2 was predicted to be at 
51 °C and 105 bar (1523 psi) (Figure 12). In short, when the pressure and temperature is 
below the critical values of the binary mixture, the mobile phase is actually a simple mixture 
of liquefied CO2 gas and organic solvent. This mobile phase nevertheless has an advantage 
over ordinary liquid mobile phases in having lower viscosity and easy recovery of the sample 
solute by decompression (Saito, 2013; Poe et al., 2014). 
 
Figure 12. Phase diagram indicating the relationship between CO2 and methanol in SFC by calculating the critical 
temperature, pressure and mass % of a CO2-methanol mixture (Saito, 2013). 
 
Most of the active pharmaceutical ingredients abused today are basic, as for the analytes of 
interest in this thesis work. When analyzing these basic entities, an additive is often required 
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added to the modifier, as the basic sites on the molecules not only become ionized, but also 
interact with the silanol groups of the silica support  (Neue et al., 2004; Hamman et al., 2011). 
The result can be broad peaks that provide very little, if any, resolution. Since the CO2 – 
methanol mixture is acidic, with a pH that might be nearly 4-5, basic compounds will 
predominately be in their cationic, protonated form (Wen and Olesik, 2000; West, 2013; 
Lemasson, et al., 2015a). Acidic compounds on the other hand, will mainly be in their anionic 
form, depending on their pKa values. Basic additives with a pH above the pKa of the analyte 
will restore the neutral state of basic species and deprotonate acidic species. Addition of an 
additive can also affect the retention by creating interactions with the analytes and thus 
increase the analytes’ affinity for the mobile phase. The additive can also compete with the 
analytes for the hydrogen bonding donor and acceptor sites of the stationary phase (Ren-Qi et 
al., 2012; Desfontaine et al., 2015). Under the acidic conditions created by the CO2 – alcohol 
mixture, any ionisable group on the stationary phase could be charged. The silanol groups 
could become partly anionic, while amino or pyridine bonded ligands could be partly cationic, 
resulting in a probable poor robustness (West, 2013). 
The use of packed column SFC for basic analytes favors the use of NH3 additives, for the 
promotion of solubility and for the compatibility to MS detection (West, 2013). The effect of 
an organic modifier alone is usually insufficient to overcome the chromatographically 
deleterious effects of residual silanol groups and to enable the elution of very polar or basic 
compounds. The role of an additive includes providing coverage of the active sites and 
changing the stationary phase and mobile phase polarity. 
Water is an alternative additive, either as the only additive or as a second additive in the 
mobile phase mixed with another additive. Water has very low solubility in supercritical CO2 
(~0.1 %, w/w), due to its high dipolar nature in contrast with the apolar CO2 (Tassaing et al., 
2004; Oparin et al., 2005; Nováková et al., 2014). Nevertheless, a small amount of water is 
miscible with supercritical CO2 when combined with an organic modifier. Water has twice the 





Figure 13. Equilibrium of water and CO2, creating carbonic acid (adapted from Nováková et al., 2014). 
The addition of water could improve the elution of polar analytes and is increasingly used as 
an alternative additive in SFC (Taylor, 2012; Lemasson et al., 2015a; Nováková et al., 2015; 
Pauk et al., 2015). 
SFC is mostly operated in normal-phase mode, which functions by using polar-polar 
interactions between analytes and the stationary phase. The stationary phases most commonly 
used in SFC were initially developed for HPLC use, thus based on silica with different 
bonding chemistries with a wide number of functional groups (alkyl, phenyl, cyano, amino, 
propane-diol etc.) or coated with polymers (West and Lesellier, 2006a,b,c; West and Lesellier, 
2008b; West et al., 2012a; da Silva et al., 2013).  The ethylene bridged hybrid (BEH) 
stationary phase was originally developed for HPLC and UHPLC, and is now marketed as 
suitable for SFC analysis due to its durable nature. The stationary phase is based on BEH 
particles, which has no ligand bonded to the surface (Figure 14). Without ligands, the analytes 
are provided access only to silanols and the BEH particle has been proven to exhibit high 
chemical and physical stability. An unbonded particle simplifies the interaction between 
analytes and provides a single source of retention on the stationary phase. The particles are 
made of a hybrid of silica and polymers, creating a durable material which is known to 




Figure 14. The stationary phase chemistry of BEH (waters.com). 
The TORUS columns of Waters corp. are modified BEH particles. The silanol seats are 
ligated with 2-picolylamine (2-PIC, Figure 15), diethylamine (DEA, Figure 16), or 1-
aminoanthracene (1-AA, Figure 17). The compounds are meant to shield the silanol seats 
from the direct or indirect bonding of modifier or additive, which over time reduces the plate 
number of the column.  
 
Figure 15. The stationary phase chemistry of 2-PIC (waters.com). 
 
Figure 16. The stationary phase chemistry of DEA (waters.com). 
 




The chiral column from Waters corp. with a amylose tris(3,5-dimethylphenyl)carbamate 
(AMY1, Figure 18) stationary phase is made to distinguish between enantiomers, 
stereoisomers, metabolites and other compounds with high resemblance (Figure 17). The 
stationary phase consists of repeated amylose tris(3,5-dimethylphenyl)carbamate units, which 
consists of a single enantiomer of the saccharide, creating a single-enantiomer stationary 
phase of which the analytes will have different affinity towards (Li et a., 2010). Normally, 
such CSPs are applied for the distinction of enantiomers, but a recent study has illustrated the 
benefits of SFC using CSPs in method 
development for separating multicomponent 
mixtures of closely-related achiral analytes 
as well (Regalado and Welch, 2015). 
Figure 18. The stationary phase chemistry of amylose 
tris(3,5-dimethylphenyl)carbamate (adapted from 
Chiraltech). 
It is advantageous that there is such a large variety of stationary phases which can be used in 
SFC without much precaution. However, the greatest difference between LC and SFC is in 
the nature mobile phase being with and without water, respectively. Thus, the knowledge 
acquired about these stationary phases in LC is generally of little guidance when working 
with supercritical fluids (West and Lesellier, 2008b).  
 
2.4.5 Challenges of supercritical fluid chromatography 
 
There have been a few technical issues that have limited adoption of SFC technology, first of 
which is the high pressure operating conditions. High-pressure vessels are expensive and 
bulky, and special materials are often needed to avoid dissolving gaskets and O-rings in the 
supercritical fluid. A second drawback is difficulty in maintaining pressure (back pressure 
regulation). Whereas liquids are nearly incompressible, so their densities are constant 
regardless of pressure, supercritical fluids are highly compressible and their physical 
properties change with pressure - such as the pressure drop across a packed-bed column. 
Currently, automated back pressure regulators can maintain a constant pressure in the column 
even if flow rate varies, mitigating this problem. A third drawback is difficulty in gas/liquid 
separation during collection of product. Upon depressurization, the CO2 rapidly turns into gas 
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and aerosolizes any dissolved analyte in the process (Smith, 1999; Hicks et al., 2016; 
Fountain et al., 2014; Lesellier and West, 2015). 
The back pressure regulation (BPR) has been one of the biggest pit falls of traditional SFC. 
As back pressure greatly affects the mobile phase density and consequently the analyte 
solvation and retention as well, its control has been key to improve the instrumentation. The 
challenges have been caused by multiple factors; poor pressure monitoring at the BPR, slow-
to-respond feedback loops, low-resolution stepper motors, poor control of pressure and flow 
at the pump, and degradation of BPR components over time (Fountain et al., 2014). 
 
2.5 Mass spectrometry  
 
 MS is a technique that identifies molecules based on their mass-to-charge-ratio (m/z) of their 
molecule fragments. MS is one of the most common techniques used in analytical chemistry 
to detect analytes. The spectra obtained by MS can be used to quantitatively or qualitatively 
determine analyte existence in an unknown sample, find the elemental or isotopic signature of 
an analyte, the masses of molecules, and to elucidate the chemical structures of molecules.  
MS works by separating the ions in a sample based on the fact that they will behave 
differently depending on their mass-to-charge ratio. There is a variety in the different physical 
principles upon which MS can be based on. In general all are divided into three steps: A 
sample introduction system where the analytes are ionized, a mass analyzer that separates ions 
based on their m/z ratio, and a detector that collects the ions.  
Ionization, separation and detection can be performed in several ways. In this study ionization 
was performed by ESI+, separation was performed by a triple quadrupole mass analyzer, and 
detection was performed by a photomultiplicator.  
 
2.5.1 Electrospray ionization 
 
Electrospray ionization (ESI) is performed with a high electrical field. The analyte is 
introduced into the MS in a volatile mobile phase, in this case CO2 and methanol. The flow 
passes through a narrow capillary and when exiting the capillary the flow is exposed to an 
electrical potential between the capillary tube and a counter electrode. The potential required 
depends on the surface tension of the solvent. Opposing forces between like charges make the 
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droplet expand until it ruptures, producing an aerosol made up from many small droplets with 
electrical charge. The aerosol passes an inert drying gas (typically N2), typically at 500-650 
°C, which evaporates and eliminates the solvent. With sufficiently high surface tension, ions 
from the droplets are released and are carried into the MS. Figure 19 shows the schematic 
overview of an ESI process. The ESI is considered a relatively soft ionization technique, 
denoting that mainly unfragmented molecular ions are produced. Both positive and negative 
ions can be produced by ESI via the electrochemical oxidation and reduction. The reactions 
depend on concentration of analyte, and the amount of ions detected per time unit is limited 








2.5.2 Quadrupole mass analyzer 
 
Work performed in the late 1800s in the search of a model to describe the fundamental matter 
was undertaken by chemists and physicists such as Dempster, Aston and so on. 
Independently, they made advances in the field of physics, and more specifically concerning 
the behavior of small particles like atoms, molecules and electrons when exposed to 
ionization and electrical or magnetic fields, which lead to the first model of a mass 
spectrograph. Their fundamental work lead to combination of insights which provided a 
foundation for the creation of the important technique of mass spectrometry. The modern 
deflection-type instruments and techniques all bear some resembles to the original models of 
Dempster, Wein, Thomson and Aston (Dempster, 1918; Aston, 1927; Münzenberg, 2013; 
Sharma, 2013). The resemblance is in the deflection of charged particles by a combination of 
electrical and magnetic fields, but the apparatuses first developed by Aston and Dempster 
bear an even stronger resemblance to the modern-day instruments.  
In practice it is difficult to achieve stable and spatially uniform magnetic fields, in particular 
with permanent magnets due to fluctuations in thermal and magnetic energy, even in a 
thermally stable environment. Many factors affect magnet stability include time, temperature, 
reluctance changes, adverse fields, radiation, shock, stress, and vibration. These variations 
lead to mass resolution degradation and calibration drifts. In the early 1950s Paul 
accomplished using alternating quadrupolar electric fields; hence the instrument was named 
Quadrupole Mass Spectrometer (Paul and Steinwedel, 1953). This clever design eliminated 
the problems associated with permanent magnets, was highly stable and provided excellent 
mass resolution. The Quadrupole Mass Spectrometer operates by applying the elegant 
mathematic equation of Mathieu (1868), which describes the passage of ions through the 
alternating quadrupolar electric field, as shown 
in Figure 20.  
The instrument consists of four cylindrical rods 
with a specific ratio of rod diameter-to-spacing, 
which make it easier to attain adequate 
hyperbolic shaping of the rods.  




2.5.3 Tandem mass spectrometry 
 
By MS/MS it is possible to increase sensitivity compared to using MS only. The technique 
uses two consecutive mass analyzers, which opts for selective examination specific ion 
fragmentations in mixtures of ions.  
Three quadrupoles connected linearly is known as a triple quadrupole tandem mass 
spectrometer (Figure 21). The first (Q1) and third (Q3) quadrupoles functiones as mass filters, 
while the second (Q2) is employed as collision cell. The first quadrupole is used to select a 
precursor ion. In the collision cell, the analytes are subject to radio-frequency potential only. 
By using an inert gass, such as argon or nitrogen, the analytes can collide and dissociate to 
form distinctive daughter ions. The daughter ions produced in the collision cell can be filtered 
in the third quadrupole (Hoffmann and Stroobant, 2007). 
 





3.1. Ultra high performance supercritical fluid chromatography 
 
The SFC instrument (Figure 22 and 23) applied in this thesis work was an Acquity Ultra 
Performance Convergence Chromatography (UPC
2
), which was introduced by Waters 
(Milford, MA, USA) in 2012. The UPC
2
 instrument is a modified Acquity UHPLC system, 
equipped with an efficient, integrated device to compress and chill the CO2 before entering 
the system. Integrating this device is preferable compared to a separated unit, as the path 
between the chilling unit and the pump can result in density variations (Fountain et al., 2014). 
Good control of both pressure and temperature is achieved by cooling of the pump heads with 
a Peltier module, which results in less density variations and thus improved repeatability and 
sensitivity. The instrument is also equipped with a dual stage back pressure regulator (BPR), 
enabling better pressure control within the system. Dual-stage refers to the design of the BPR 
performing a combination of an active and a static pressure control. The static BPR ensures 
that the pressure is kept above a minimum, while the active BPR enables greater control to 
fine-tune the back pressure. To improve robustness, the static component of the BPR is heated 
to mitigate problems of ice formation as CO2 expands adiabatically. The maximum pressure 
and flow of the instrument are 6000 psi and 4 mL/min, respectively (Fountain et al., 2014; 





Figure 22. Schematic overview of the UPC
2
-instrument, modified version of the one from the Waters to more accurately 




Figure 23.  The SFC instrumentation coupled to a MS from Waters corp., including a binary solvent manager (BSM), 
Sample Manager (SM), Convergence Chromatography Manager (CCM), Column Manager (CM), Photodiode Array (PDA) 
Detector (not including in the instrument used in this thesis work), Make-Up Flow Pump with additional Pump Control 
Module (PCM).The MS splitter is used to efficiently merge the SFC components with optimum MS detection. Insert: 
overview of the MS splitter (Fogwill, 2015). 
 
3.1.1 Chromatographic screening conditions 
 
In order to investigate the selectivity, different stationary phase chemistries and mobile phases 
were tested. The chromatographic screening conditions used for UHPSFC are listed in Table 
2, while Table 3 shows the UHPLC conditions used for the analysis of phospholipids and 2-, 
3-, 4-methylamphetamine.  
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Partial loop with needle overfill 
   



























































40  mM NH3 (dissolved in methanol) 
 
A: CO2 
B: Methanol with 40 mM NH3 
Time (min)      Component A/B 
Initial                98 % A : 2 % B 
0.2                    98 % A : 2 % B 
0.3                    90 % A : 10 % B 
2.0                    76.5 % A : 23.5 % B 
2.5                    60 % A : 40 % B 
3.5                    60 % A : 40 % B 





















BEH (Waters corp.) 
 




59 µL (Grand-Guillaume Perrenoud et al., 
2013) 








Table 3. UHPLC instrument parameters  
  




Partial loop with needle overfill 
   
 Injected volume     1.0 µL   













  Water and methanol (95:5) 
 










































A: 5mM ammonium formate 
B: Methanol  
 
Time (min)      Component A/B 
 
Initial                95 % A : 5 % B 
0.15                  95 % A : 5 % B 
0.30                  90 % A : 10 % B 
16.00                60 % A : 40 % B 
16.50                2 % A : 98 % B 
17.00                2 % A : 98 % B 
17.50                95 % A : 5 % B 
18.00                95 % A : 5 % B 
 
Initial                98 % A : 2 % B 
5.00                  60 % A : 40 % B 












BEH (Waters corp.) 
 
3.0 mm x 100 mm 








3.1.2 Investigated UHPSFC columns 
 
To examine the selectivity of attainable columns, five different stationary phase chemistries 
were tested; Ethylene bridged hybrid (BEH), 2-picolylamine (2-PIC), diethylamine (DEA), 1-
aminoanthracene (1-AA) and amylose tris(3,5-dimethylphenyl)carbamate (AMY1) from 
Waters corp. All the columns had dimensions of 3 mm x 100 mm, with 1.7 µm diameter of 
the particles, expect for the AMY1 column which had dimension of 4.6 mm x 100 mm and 
2.5 µm diameter particles. All stationary chemistries of the tested SFC columns are described 
in chapter 2.4.4. 
3.2. Tandem mass spectrometry 
 
For the tandem MS detection a Xevo TQ-S MS from Waters corp. (Milford, MA, USA) was 
used. Detection was performed with positive electrospray ionization (ESI
+
) in MRM mode. 
Table 4 shows the different MS specification used in this thesis work. Table 5-7 shows the 
different analyte and internal standard (IS)-transition ions, with associated mass spectrometric 
parameters. 
Table 4. MS parameters for all experiments. 
          
Mass analyzer       
  
  LM1 resolution 2.7     
  HM1 resolution 14.7     
  Ion energy 1 0.5 V   
  Collision energy 2.0 (MS mode collision energy) 
  Collision gas flow 0.2     
  Ion energy 2 1.0 V   
  LM2 resolution 2.8     
  HM2 resolution 14.8     
          
MS-source     Annotation   
  Capillary voltage 1.0 kV   
  Desolvation gas temperature 600 °C   
  Desolvation gas flow 900 L/Hr   
  Cone voltage 30 V   
  Cone gas flow 300 mL/min   
  Source temperature 150 V   





Table 5. MRM transitions and compound specific MS settings of the 2-, 3-, 4-isomers. 
               












              
2-, 3-, 4-
methylmethcathinone 
            
Quantifier 178.10 > 119.00 44.0 20.0 0.008 
Qualifier 178.10 > 145.10 44.0 18.0 0.008 
              
2-, 3-, 4-
fluoroamphetamine 
            
Quantifier 154.10 > 109.00 20.0 15.0 0.008 
Qualifier 154.10 > 137.10 20.0 8.0 0.008 
              
2-, 3-, 4-fluoromethamphetamine           
Quantifier 168.10 > 109.00 20.0 18.0 0.008 
Qualifier 168.10 > 137.10 20.0 10.0 0.008 
              
13
C6-PMMA             
Quantifier 186.16 > 127.09 20.0 14.0 0.008 
Qualifier 186.16 > 155.12 20.0 14.0 0.008 





Table 6. MRM transitions and compound specific MS settings of the classical phenethylamines. 
               












              
Amphetamine             
Quantifier 136.11 > 91.05 15.0 12.0 0.008 
Qualifier 136.11 > 119.09 15.0 12.0 0.008 
              
Methamphetamine             
Quantifier 150.13 > 91.05 15.0 14.0 0.008 
Qualifier 150.13 > 119.09 15.0 14.0 0.008 
              
MDMA             
Quantifier 194.12 > 133.07 20.0 14.0 0.008 
Qualifier 194.12 > 163.08 20.0 14.0 0.008 
  
 
             
13
C6-Amphetamine             
Quantifier 142.13 > 97.07 15.0 12.0 0.008 
Qualifier 142.13 > 125.11 15.0 12.0 0.008 




            
Quantifier 156.15 > 97.07 15.0 14.0 0.008 
Qualifier 156.15 > 125.11 15.0 14.0 0.008 
              
13
C6-MDMA             
Quantifier 200.14 > 139.09 20.0 14.0 0.008 
Qualifier 200.14 > 169.10 20.0 14.0 0.008 





Table 7 displays the MS settings used to scan for the parent ion of phospholipid, when 
evaluating different extraction techniques with respect to their ability to remove 
phospholipids. 
Table 7. Settings for the MS analysis of phospholipids used for the evaluation of extraction agents. 






   
           
Phospholipids          
Parent ion 184.40 > 184.40    
              
 
3.3 Other equipment 
 
The whirl mixer used was supplied by Heidolph (Schwabach, Germany). For centrifugation a 
Thermo Fisher Scientific Multifuge X3R was applied from VWR (Oslo, Norway). The N2-
evaporator RapidVap Vertex Evaporator was provided by Labconco (Kansas city, Missouri, 
USA). For the tilting of samples a tilting machine built by local technician at NIPH was 
applied. Nitrogen used for MS desolvation was produced by a nitrogen generator (Oxymat, 




The CO2 gas was purchased from Yara Praxair (Oslo, Norway) as food grade (99.8 %), while 
the methanol used was LC-MS Chromasolv purchased from Sigma Aldrich (St. Louis, MO, 
USA). Ethanol was absolute and purchased from Merck Millipore (Billerica, MA, USA). 
Isopropanol, heptane, ethyl acetate, HNO3 (65 %, dissolved in methanol), HPLC-grade 
methyl tert-butyl ether (MTBE) and 25 % (v/v) aqueous NH3 for analysis was purchased from 
Merck as well. The NH3 dissolved in methanol (2M) was purchased from Sigma Aldrich (St. 
Louis, MO, USA). Acetonitrile was HPLC-grade from J. T. Baker (Center Valley, PA., USA). 
Formic acid (98 %) was supplied by VWR (Oslo, Norway). Cyclohexane was supplied by 
Rathburn (Walkerburn, UK). Water used for analysis was purified by filtering deionized 
water on a Milli-Q filtration system (Millipore, Bedford, MA, USA). Argon gas (99.999 %) 
was supplied by AGA (Oslo, Norway).  
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2- and 3-methylmethcathione were supplied by Cayman Chemical Company (Ann Arbor, 
Michigan, USA), while 4-methylmethcathione and amphetamine was supplied by Sigma 
Aldrich (St. Louis, MO, USA). 2-fluoroamphetamine was purchased from Alfa Aesar 
(Heysham, Lancashire, UK). 3-, 4-fluoroamphetamine, 2-, 3- and 4-fluoromethamphetamine 
and the 2-, 3- and 4-methylmethamphetamine were purchased from Chiron AS (Trondheim, 
Norway). Methamphetamine and MDMA were purchased from Cerilliant Corporation (Round 
Rock, Texas, USA). The structures of the analytes of interest are shown in Figure 24. The pKa 
and log P for the analytes of interest are listed in Table 8. 
 





Table 8. Table of pKa and log P for all analytes. 
 




10.13, at 20 °C (Perrin, 1965) 
 
1.76 (Hansch et al., 1995) 
Methamphetamine 9.87 at 25 °C (Perrin, 1965) 2.07 (Hansch et al., 1995) 
MDMA  10.14 (drugbank.ca) 1.07/1.27 (drugbank.ca) 
2-, 3-, 4-Fluoroamphetamine        
2-, 3-, 4-Fluoromethamphetamine        
2-, 3-, 4-Methylamphetamine        
2-, 3-, 4-Methylmethcathinone        
 
The values of the constitutional isomers of the new designer drug versions of amphetamines 
are estimated to be somewhat the same as for amphetamine and methamphetamine. The small 
differences in structures should not affect their values, especially since the functional group of 
the molecule is not changed and the alteration is on the opposite side of the phenyl ring.  
 
3.5 Internal standards 
 
Stable internal standards (ISs) were used to correct for lost analyte during sample preparation 
and variations during instrumental analysis. Deuterium (
2
H) labelled ISs are commonly used 
in forensic toxicology to ensure qualitative and quantitative detections. However, for optimal 
correction for loss of analyte and possible MEs 
13
C-labelled ISs are preferred over 
2
H-labelled 




H-labelled ISs are routinely used at NIPH, and 
13
C-labelled ISs were applied for this method. The calculations of the concentrations of IS-
solutions are shown in Appendix I. All IS compounds were obtained from Chiron AS 





Figure 25. Structures of the 
13
C6-labelled IS used for this thesis work (made at emolecules.com and modified in paint). 
 
3.6 Solutions 
3.6.1 Preparation of Stock Solutions, Standards and Control Samples 
 
Table 9. Standard and control Samples
 
The stock solutions were prepared by dissolving an appropriate 
quantity of the standard compound in pure methanol and were 
stored at -20 °C. Working solutions for calibrator and quality 
control samples were further eluted from these ready-to-use stock 
solutions and kept refrigerated at 4 °C. The solvent chosen for all 
working solutions was isopropanol.  
The solutions were separated into two sets; A and B. The A 
solutions contained amphetamine, methamphetamine and 
MDMA, while the B solutions contained 2-, 3-, 4-
fluoroamphetamine, 2-, 3-, 4-fluormethamphetamine and 2-, 3-, 4-
methylmethcathinone. The analytes were separated due to their coelution and probable effect 
on ion detection either as ion suppressive or ion enhancing. The concentration levels are 





Standard 1 0.010 
Standard 2 0.10 
Standard 3 1.0 
Standard 4 10 
Standard 5 4.0 
Control 1 0.0010 
Control 2 0.0050 
Control 3 0.010 
Control 4 0.10 
Control 5 1.0 
Control 6 10 
Control 7 5.0 




3.6.2 Blank blood  
 
Whole blood containing 2 g sodium fluoride, 6 mL heparin and 10 mL water per 450 mL 
blood was used for development and validation of the method, and was purchased from the 
blood bank at Oslo University Hospital (Oslo, Norway). Different lots of human blood were 
used.  
 
3.6.3 Preparation of modifier  
 
The modifier solution consisting of 40 mM NH3 in methanol used for the UHPSFC analysis 
was prepared by the addition of 5 mL NH3 solution (2 M in methanol) in 250 mL methanol. 
The modifier solution consisting of 0.3 % NH3 in methanol used for the UHPSFC analysis 
was prepared by the addition of 3 mL NH3 solution (25 %, v/v) in 250 mL methanol. The 
calculations related to these solutions are displayed in Appendix II. 
 
3.6.4 Preparation of buffer used for UHPLC analysis 
 
The 50 mM ammonium formate stock solution used for the UHPLC analysis was prepared by 
dissolving 6.3 g of ammonium formate in 2000 mL MilliQ water. The 5 mM ammonium 
acetate buffer solution was prepared by dissolving the 50 mM stock solution by 1:10. The pH 




3.7 Sample preparation  
 
3.7.1 Sample preparation equipment 
 
The SPE filters applied were Supelco Hybrid SPE from Sigma Aldrich (St. Louis, MO, USA), 
Oasis PRiME HLB from Waters corp. (Milford, MA, USA) and Phree from Phenomenex Aps 
(Torrance, CA, USA). All filters had a sample volume of 1 mL (30 mg). 
 
3.7.2 Method procedure  
 
 All working solutions and blank blood from were set in room temperature to temperate. 
Blank blood of 100 µL was added to all blanks, standard and control samples. All working 
solutions were whirl mixed before use. To each standard and control samples (in accordance 
with Table 9) 100 µL of working solution was added, while 100 µL of distilled water (MilliQ 
H2O) was added in the blank samples. Subsequently, 50 µL of internal standard was added in 
all samples and all samples were whirl mixed. Ammonium carbonate buffer (pH 9.3) was 
added in all samples at a volume of 100 µL and all samples were whirl mixed again. To 
extract the analytes from the blood matrix, 1000 µL of ethyl acetate and heptane (80:20, v/v) 
was added in all samples and then tilted for five minutes. Centrifugation was executed at 3500 
min
-1
, in 6 °C for five minutes. Transfer of 800 µL of the organic phase to new plastic tubes 
was followed by addition of 10 µL 0.1 % HNO3 solution in all samples. All samples were 
evaporated until complete dryness in the N2-evaporizer for 10 minutes, at 20 psi and 45 °C. 
The residues were reconstituted in 60 µL isopropanol and whirl mixed before transfer to 
autosampler vials and injection into the UHPSFC-MS/MS. 
 
3.8 Data Analysis  
 
MassLynx software version 4.1 obtained from Waters was used for instrument control, data 





3.9 Method validation  
 
Method validation was performed to confirm that this analytical procedure is suitable for its 
intended use. The data obtained can be used to evaluate the quality, reliability and consistency 
of the method. All validation parameters were executed in concordance with the validation 
regime of NIPH and by using blank blood spiked with the different analytes.  
 
3.9.1 Interday precision and accuracy 
 
Interday precision was defined as the measure of the closeness of agreement between a series 
of measurements obtained from multiple samplings of the same homogenous sample. It is 
expressed numerically as imprecision. Interday accuracy is defined as the closeness of 
agreement between the mean of the results of measurements of a measurand and the true (or 
accepted true) value of an analyte. It is reported as a percent difference.   
Precision and accuracy was determined for all analytes in the concentration range of 0.001 – 
10 µM for the 2-, 3-, 4-isomers and in the range of 0.005 – 10 µM for the classical 
amphetamines. The calculation was based on eight series. 
 
3.9.2 Intraday precision and accuracy 
 
Intraday precision and accuracy of the method within a single series is a measure of the 
repeatability within one assay of analysis. Accuracy is calculated as percent deviation from 
the nominal value. The precision of the intraday (within-series) measurements was expressed 
as relative standard deviation (RSD). Repeatability was measured by ten parallels of each 
analyte at two different concentration levels; 0.25 and 1.0 µM.  
 
3.9.3 Linearity  
 
Linearity is defined as a measure of the range in which there will be a correlation between 
signal response (e.g. peak ratio of analyte and internal standard) and an analyte concentration 
in the sample. Linear weighted (1/x) calibration curves were chosen for this method. For the 
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2-, 3-, 4-isomers 
13
C6-PMMA was used as IS, while amphetamine, methamphetamine and 
MDMA used corresponding 
13
C6-labelled IS. Linearity was measured with extracted samples 
with a concentration of 0.001, 0.005, 0.010, 0.100, 1.00, 2.00, 4.00, 6.00, 8.00 and 10.00 µM. 
 
3.9.4 Limit of detection and limit of quantification  
 
Limit of detection (LOD) is the lowest concentration of analyte which can be confirmed to be 
present in the sample. Limit of quantification (LOQ) is the lowest concentration which can be 
quantified with satisfactory precision. Both have, in this thesis work, been determined by 
equation 4 and 5, respectively. 
                                                      Eq. 4 
   
                                                      Eq. 5 
 
3.9.5 Matrix effect 
 
The matrix effect (ME) is a measure of the combined effect of the sample other than the 
analyte on the measurement of the quantity. In order to evaluate ME corrected with IS two 
concentration levels and injections volumes were chosen; 0.1 and 1.0 µM, 0.5 and 2.0 µL. 
Five different lots of blank human blood from the blood bank at Oslo University Hospital 
(Oslo, Norway) were used with two parallels of each. 
Sample preparation was based on two sets of sample extracts. The first set consisted of ten 
extracts of the blank matrices spiked with the analytes of interest, added post extraction, using 
five lots of blank blood and two parallels of each lot. The second set consisted of four 
parallels with neat solutions containing equivalent amounts of compound of interest prepared 
in autosamplervials. The same procedure was performed for both concentration levels and all 
samples were extracted and analyzed the same day.  After extraction and prior to evaporation, 
IS was added to the first set of samples. The calculation of ME was performed by dividing the 
mean peak height of the samples spiked after extraction (A) with the mean peak height found 
in the neat solutions (B) (eq. 6). The calculation of corrected ME was performed using the 




    
 
 
          Eq. 6 
   
             
 
 
        Eq. 7 
A value above 100 % indicates ion enhancement, and a value below 100 % indicates ion 
suppression. RSDs were calculated based on the variation of the peak height s of the analytes 
in the five spiked extracts or the variation of the peak heights corrected with the peak heights 
of the IS. Acceptable values of ME are between 75 and 125 %, with RSDs ≤ 25 % when using 
deuterated ISs (Paul et al., 2009). 
 
3.9.6 Extraction recovery 
 
Extraction recovery (%)  is a measure of the amount of analyte attainable from the extraction 
process chosen and was measured at two concentration levels with three parallels of each 
concentration and two different lots of blank blood (n=6).  
The recovery was calculated by comparison of the calculated concentrations obtained for the 
validation samples with the analytes added before extraction and the IS were added after 
(n=6), with the samples obtained when both the analytes and the IS were added after the 
extraction step (n=4). 
 
3.9.7 Carry-over  
 
Carry-over was examined by injection of a samples with a concentration which the highest 




The specificity of the method was investigated by analysis of a fortified sample with some 
commonly found drugs of abuse (n = 25). The chromatograms were evaluated for interfering 
peaks at the same retention time as the analytes of interest. The analytes and their respective 
concentrations are shown in Appendix VII, Table VII e. Additionally, eight blank samples 
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4 Results and discussion 
 
In this thesis work a method was developed which could separate and distinguish a group of 
new synthetic amphetamines by a UHPSFC-MS/MS method. Traditionally, LC is applied for 
such compounds. However, this is intrinsically difficult due to the similarity between these 
isomers. The use of UHPSFC opens for additional ways to affect the elution and separation of 
analytes by adjusting more parameters attainable than in LC.  
 The group of analytes of interest in this thesis work are all new psychoactive substances and 
are attainable in three different positional isomers. These substances are listed in chapter 3.4, 
including their structural formulas in Figure 24. Since the abuse of these compounds is often 
accompanied with the abuse of the traditional amphetamines, intentionally or unintentionally 
due to impurities or dilution of illicit drugs, the validation performed included the classical 
phenethylamines amphetamine, methamphetamine and MDMA. 
 
4.1 Sample preparation 
 
All biological samples contain a complex mixture of molecules. In order to perform a robust 
and efficient chromatographic and mass spectrometric analysis of biological samples it is 
important to get rid of possible contaminants and also to retain as high a percentage of analyte 
as possible.  
For the method in question whole blood was chosen as sample agent. Blood is generally 
considered to be the sample specimen that shows the best correlation between drug 
concentration and pharmacologic effect, as it reflects recent intake and can be used to assess 
impairment (Gjerde et al., 2011). Phospholipid removal was considered to be an important 
evaluation point when considering different extraction methods, as removal of phospholipids 
from blood samples is crucial in order to avoid smudging and contamination of the MS. 
Additionally they could co-elute and ionize with the analytes of interest. A possible co-elution 
would result in ion-suppression of the MS signal that would cause variability and could lessen 
the accuracy of the methods result. There are also other sample matrix elements which could 
compromise the system, such as various proteins, which can precipitate in the SFC column 
(Wu et al., 2008). Both SPE and LLE techniques were tested and are theoretically described 
in chapter 2.3.   
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4.1.1 Evaluation of extraction method 
When choosing an appropriate extraction method, there were several factors to take into 
account. There should be adequate analyte yield, when extracting the analytes from the 
sample matrix. Meaning that the resulting extract should contain an amount of analyte 
molecules, which is representative for the primary sample. Furthermore, it is desirable to 
remove as much as possible of the redundant compounds of the extract, particularly 
troublesome components like blood proteins and phospholipids as they can cause 
contamination and compromise of the analysis result. The total cost must also be taken into 
account. Additionally, it is more cost efficient to apply one of the methods already used in the 
laboratory which will implement the technique. Among the routinely applied techniques in the 
sample preparation methods of the NIPH’s forensic department, are SPE and LLE. Choosing 
an extraction method that is already in use, would be practical considering required 
appliances, purchase and storage of reagents. Time consumption is an important factor to take 
into consideration. There is a wish for developing more rapid sample preparation methods in 
order for results to be quickly dispatched to the requisitioner, but also time consumption is an 
extension of the cost evaluation. Sample preparation is often the most labor intensive part of 
the method procedure as the instrumental analysis is highly automated. The methods technical 
degree of difficulty will affect time consumption and a method which is technically advanced 
will more often be prone to error than more simplistic ones. Safety must also be taken into 
consideration, especially for the hazardous solvents used in LLE.  
Three SPE filters and three LLE solutions were tested, see Table 10 and 11. 
 
Table 10. SPE filters applied for the evaluation of 
extraction methods. 
 








SPE filters     
 
LLE solutions   
       Supelco Hybrid SPE 
   
Cyclohexane 
 
       HLB Prime 
   
Ethyl acetate and heptane (80:20) 
       Phree 
   




Supelco          Parent of 184 ES+ 
Hybrid SPE                              TIC 
1.45e8 
Oasis               Parent of 184 ES+ 
PRiME HLB                         TIC 
2.24e8 
Phree            Parent of 184 ES+ 
TIC 
2.58e6  
Protein            Parent of 184 ES+ 
precipitation                           TIC 
1.50e9 
Protein precipitation by acetonitrile and methanol (85:15) was also tested and used as a frame 
of reference between the different methods as it removes less phospholipids compared to the 
SPE filters and LLE solutions chosen. All the sample preparation techniques were tested on 
their ability to remove phospholipids and appropriate analyte yield with UHPSFC-MS/MS 
analysis (data not shown). All extracts showed satisfactory peak height for all analytes, while 
only the chosen extraction technique was quantitatively evaluated upon its extraction yield.  
The SPE cartridges Supelco Hybrid SPE and Oasis PRiME HLB, both showed satisfactory 
removal off phospholipids. The Phree plate however, showed a superior performance with a 
close to complete removal of phospholipids (see Figure 26 and 27). Nevertheless, the Phree 
plate demanded quite high vacuum in order for the fluid to flow through. This makes this 
method more difficult and time consuming to use in a routine application. Experiment design 
for the evaluation of extraction agent is shown in Appendix V. 
 





Figure 27. UHPLC-MS/MS analysis of blood extracts from SPE and from protein precipitation. UHPLC-MS/MS analysis 
were performed by parent ion scan of m/z 184. Protein precipitation (red), Supelco Hybrid SPE (black), Oasis PRiME HLB 
(purple) and Phree (green) 
Another consideration to make for the appropriate sample extraction technique was the 
quantity of samples. As the analytes of interest are not as common as their phenethylamine 
cousins’ amphetamine, methamphetamine and MDMA, the analysis will not produce more 
than a handful of samples per month in average.  Not all SPE products are produced as single 
cartridges, but rather as 96-well plates. All the SPE techniques tested in this thesis work were 
attainable as single cartridges. Ostro SPE filter from Waters corp. was also considered, but 
was omitted as it is only attainable in 96-sample plates. As this method is a low sample 
volume method, there is not a large enough sample volume for the use of 96-sample plates. 
The most phospholipids in whole blood were removed by LLE (Figure 28 and 29) and the 
recovery of analytes after extraction was considered satisfactory with cyclohexane and ethyl 
acetate and heptane (80:20) as a high analyte signal was produced (> 10
8
, shown in Appendix 
V). Among the solvents used for LLE, cyclohexane is more volatile and hazardous than the 
other two options. As cyclohexane also did not provide any advantage over the others, it was 
not considered to be the best option. Ethyl acetate and heptane (80:20) was chosen as the best 
option for this method procedure, due to appropriate phospholipid removal (further details 
shown in Appendix V). Other mixtures of ethyl acetate and heptane were not tested as the 






Figure 28. UHPLC-MS/MS analysis of extract showing residue phospholipids after LLE techniques. LLE by cyclohexane: 






Figure 29. UHPLC-MS/MS analysis of extract showing a comparison of the residue phospholipids after LLE versus protein 
extraction techniques by overlaying graphs. Protein extraction: Black; LLE by cyclohexane: Red; Ethyl acetate/heptane 




4.2 Chromatographic separation by UHPSFC 
 
In order to distinguish between the analytes of this thesis work, chromatographic separation 
by UHPSFC was utilized. To our knowledge, until now generally HPLC and GC have been 
utilized for the separation of some of the analytes (Davis et al., 2012; Mohr et al., 2012: 
Plotka et al., 2011; Plotka et al., 2012; Röhrich et al., 2012; Santali et al., 2011; Hegstad et 
al., 2014; Wang et al., 2015). Nevertheless, there seems to be a rising interest in UHPSFC for 
the analysis of such compounds (Grand-Guillaume Perrenoud et al., 2012a; Gourmel et al., 
2013; Kalikova et al., 2014; Li and Lurie, 2014; Newmeyer et al., 2014; Pauk et al., 2015).  
In order to find the optimal conditions for the separation of the analytes a series of different 
experiments were performed. The UHPSFC technique can be varied by several parameters; 
pressure, density, co-solvent amount, additive amount, stationary phase, flow rate. The road to 
a complete method was a winding one and led to a series of additional questions and technical 
difficulties concerning the technique of supercritical fluid chromatography. 
The supercritical fluid chosen for this thesis work was CO2. Although there are other options, 
only CO2 was considered as it is by far the most commonly applied supercritical fluid due to 
its beneficial properties as explained in chapter 2.4.2.  
Although there is a high similarity between these analytes, they highly differ in their affinity 
and behavior in SFC for the conditions chosen as shown in Figure 30. The biggest difference 
is found in the functional group attached to the phenyl ring and its position. The ability to 
separate these closely related molecules can probably be accredited to these slight differences. 
Furthermore, the methyl group found on C1 of the common structure in methamphetamine, 
fluoromethamphetamine and methylmethcathinone appears to make the analytes somewhat 
more robust for chromatographic changes in the BEH stationary phase which are discussed in 







Figure 30. Optimal separation of the nine analytes of interest was found with a BEH-column, using a modifier solution of 
MeOH with 40 mM NH3, 60 ° C and 1800 psi (chromatographic and MS settings as described in chapter 3.1.1 and 3.2.1). 
Analytes from top to bottom: Methylmethcathinones (black), fluoromethamphetamines (purple) and 
fluoroamphetamines (green). 
The validation performed included the classical phenethylamines amphetamine, 
methamphetamine and MDMA. A chromatogram showing all the analytes is shown in Figure 
31. However, due to the co-elution of the classical phenethylamines with the new 
psychoactive substances, the analytes were separated into two sets of solutions, referred to as 
A (the classical phenethylamines) and B (the 2-, 3-, 4-phenethylamines). This was done in an 
attempt to alleviate the possible ion suppression effects caused by the coeluting amphetamine. 
The ion suppression effect was observed for the analytes which co-eluted with the classical 




Figure 31. Chromatogram showing all the analytes of interest. Chromatographic and MS conditions as described in 
chapter 3.1.1 and 3.2.1. Analytes from top to bottom: Amphetamine (red), methamphetamine (brown), MDMA (black), 
methylmethcathinones (black), fluoromethamphetamines (purple) and fluoroamphetamines (green). 
The 2-, 3-, 4-positional isomers of methylamphetamines were also initially included in the 
thesis work, but no conditions could be set to successfully separate these isomers (Figure 32). 
However, the methylamphetamines might be separated with a UHPLC (Figure 33). The 
chromatographic and mass spectrometric settings were comparable to the SFC settings, 
however with a slower and longer gradient with an aqueous 5 mM ammonium formate mobile 
phase and the column temperature set at 60 °C. The peaks are not baseline separated, because 
the separation was not optimized as this was beyond the scope of this thesis work. The 
analysis of the positional isomers of methylamphetamine was only tested on UHPLC to find 
an alternative way to analyze this set of isomers. The possible successful separation with 
UHPLC could suggest that a more polar solvent, such as water, is required to overcome the 
intermolecular interactions of these analytes. 
Since baseline separation of the 2-, 3-, 4-methylamphetamines was not obtained by UHPSFC-
MS/MS, the focus of this thesis work became aimed at the 2-, 3-, 4-fluoroamphetamine, 2-, 3-
, 4-fluoromethamphetamine and 2-, 3-, 4-methylmethcathinone. These nine analytes are from 






Figure 32. Poor chromatographic separation of 2-, 3-, 4-methylamphetamines with UHPSFC-MS/MS conditions. 
Chromatographic and MS conditions as described in chapter 3.1.1 and 3.2.1, respectively.  
 
Figure 33. Possible separation of the positional isomers of methylamphetamine with UHPLC-MS/MS, using a 18 min 
gradient elution with a 5 mM ammonium formate and methanol mobile phase, 60 °C, and 0.5 mL/min flow rate 
(chromatographic and MS settings are further described in chapter 3.1.1 and 3.2.1, respectively) 
 
4.2.1 Stationary phase chemistry 
 
Five different column chemistries were tested for the separation of the chosen analytes; 
 Ethylene bridged hybrid (BEH) 
 Diethylamine (DEA) 
 2-picolylamine (2-PIC) 
 1-aminoanthracene (1-AA) 
 Amylose tris-(3,5-dimethylphenyl)carbamate (AMY1) 
The choice of stationary phases tested was solely based on evaluating the available UPC
2
-
columns from Waters, as they are compatible with the instrumentation nuts and grooves of the 
UPC
2
 apparatus. There is an extensive selection of other columns from other suppliers, which 
are produced for SFC instrumentation. Among them, there might be several columns which 
can produce satisfactory separation of these analytes, but they were not considered in this 
thesis work, due to a restricted time schedule, funds and the possible detrimental effects to the 
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grooves and following leaking problems. However, the columns selected have provided us 
with a span of retention qualities. The columns selected gave a variety of results. In a recent 
paper by Lemasson et al. these columns were evaluated and rated as orthogonal to each other 
(Lemasson et al., 2015b).  
All experiments are performed at a standard linear gradient (from 2 to 40 % modifier in 4 
minutes) with a methanol modifier with 40 mM NH3, at 60 °C and 1800 psi (described in 
chapter 3.1.1), except for the AMY1 column, which due to its completely different chemistry 
only showed similar separation with a different modifier. 
The 2-PIC column produced satisfactory separation of the methylmethcathinone and 
fluoromethamphetamine isomers (Figure 34). The peaks of the fluoroamphetamine isomers 
however, experienced extensive tailing. The 2-PIC column was tested with different 
parameters (varying modifier, temperature, pressure, gradient etc., data not shown), but no 
condition could alleviate the poor chromatographic result for the fluoroamphetamine. 
 
 
Figure 34. UHPSFC-MS/MS analysis of the 2-, 3-, 4-isomers with a 2-PIC stationary phase. Chromatographic and MS 
conditions as described in chapter 3.1.1 and 3.2.1, respectively. Analytes from top to bottom: Methylmethcathinones 
(black), fluoromethamphetamines (purple) and fluoroamphetamines (green). 
 
The DEA column produced satisfactory baseline separation and peak shape for the isomers of 
fluoromethamphetamine, but no separation for the methylmethcathinone isomers and poor 
baseline separation of the isomers of fluoroamphetamine (Figure 35). The DEA column was 




data not shown), but no condition could alleviate the poor chromatographic result for the 
isomers of methylmethcathinone and fluoroamphetamine. 
 
 
Figure 35. UHPSFC.MS/MS analysis of the 2-, 3-, 4-isomers with a DEA stationary phase. Chromatographic and MS 
conditions as described in chapter 3.1.1 and 3.2.1, respectively. Analytes from top to bottom: Methylmethcathinones 
(black), fluoromethamphetamines (purple) and fluoroamphetamines (green). 
The chiral column, AMY1, was tested at several different conditions and it turned out to 
produce satisfactory separation of the analytes of interest at a different set of conditions than 
the other columns (Figure 36). The best separation was achieved using acetonitrile as a 
modifier, rather than methanol. This can probably be attributed to the chemistry of the AMY1 
column being completely different, as it not made of particles that are part silica and part 
polymer, but is rather a complete polysaccharide-based stationary phase made to distinguish 
between compounds with high resemblance. The complexity of the structure has however 
obscured the mechanism of chiral recognition, which is largely unknown for most analytes 
and CSPs.  The enantioselective environment of the AMY1 column might achieve higher 
interaction with the analytes in combination with a solvent with lower proton acceptor ability, 





Figure 36. UHPSFC-MS/MS analysis of the 2-, 3-, 4-isomers with a AMY1 stationary phase. Chromatographic and MS 
conditions as described in chapter 3.1.1 and 3.2.1, respectively. Analytes from top to bottom: Methylmethcathinones 
(black), fluoromethamphetamines (purple) and fluoroamphetamines (green). 
The 1-AA column was tested at an external laboratory, but did not produce satisfactory results 
for any of analytes (data not shown).  
The BEH column produced satisfactory results for all the analytes of interest (Figure 37). 
Several parameters were tested and are more shown in the following part chapters. Most 
conditions produced satisfactory separation of most of the analytes, but for the optimal 
separation of all analytes a middle ground was chosen.  
 
 
Figure 37. UHPSFC-MS/MS analysis of the 2-, 3-, 4-isomers with a BEH stationary phase. Chromatographic and MS 
conditions as described in chapter 3.1.1 and 3.2.1, respectively. Analytes from top to bottom: Methylmethcathinones 
(black), fluoromethamphetamines (purple) and fluoroamphetamines (green). 
Out of the five columns, the BEH column showed a superior separation compared to the 
others: The chromatographic result with the BEH column was satisfactory for the analytes of 




separation of the isomers and so on. However, over time the BEH-column displayed a high 
degree of decrease in retention time and poor separation between the positional isomers. A 
possible shielding of silanol seats over time was proposed, which might explain the reduction 
in plate numbers of the column. The TORUS columns of Waters corp. are modified BEH 
particles are meant to withstand this effect by shielding the silanol seats from the direct or 
indirect bonding of modifier or additive. However, these modifications to the BEH particles 
also decreased the separation of the analytes of interest in this thesis, indicating that it is the 
silanol seats that are responsible for the effective separation at almost any condition. This is 
further discussed in chapter 4.3.3. The AMY1 column did however produce satisfactory 
separation of the analytes of interest. Nevertheless, the peaks were not as well baseline 
separated as with the BEH column. Additionally, these polysaccharide-based columns are not 
considered to be durable under the high pH conditions that are required for the separation of 




The separation and behavior of the nine analytes of interest were investigated at different 
gradient regimes. It seems to be a non-important parameter for the relative separation of the 
analytes. Neither with nor without intermittent isocratic stages during the elution, the 
separation did not get affected in a significant way. However, the steepness of the gradient, 
thus the amount of modifier the analytes are exposed to before elution does affect the peak 
shape, retention time and the baseline separation between the isomers.  These implications 
might be due to decreased interactions between the analytes and the silanol groups on the 
silica-based stationary phase or due to improved solubility. When increasing modifier 
percentage from 2 to 8 %, followed by a linear gradient, the peak shape and baseline 
separation are improved, while retention time is decreased. Retention time decrease is more 




Increased steepness of the gradient exposes the analytes to a higher percentage of modifier at 
an earlier stage, which causes them to elute earlier (Figure 38). Additionally, the baseline 
68 
 
separation is somewhat decreased with increased modifier. High amount of modifier probably 
causes less interaction between the amphetamine analytes and the silanol seats in the 
stationary phase, outcompeting these interactions. 
 
 
Figure 38. Low vs. high amount of modifier using a linear gradient on a BEH column with a mobile phase consisting of CO2 
and  40 mM NH3 in methanol modifier. Analytes from top to bottom: Methylmethcathinones (black), 
fluoromethamphetamines (purple) and fluoroamphetamines (green). a) Gradient elution using a linear gradient from 2-
40 % modifier within 5.5 minutes. b) Gradient elution using a linear gradient from 2-40 % modifier within 4 minutes. 
Further chromatographic and MS conditions as described in chapter 3.1.1 and 3.2.1, respectively. 
 
Isocratic elution experiment 
 
In order to explore the behavior of the analytes at different modifier percentages, an isocratic 
elution experiment was designed (Figure 39). The analytes were subject to 1-20 % modifier 
(40 mM NH3 in methanol) and the run time was set at 10 minutes. No analytes eluted at 1 % 
and only 3- and 4-methylmethcathinone eluted at 2 % modifier. All analytes eluted at 3 % 
modifier and above, but showed very broad peaks at low modifier percentages. The 




methylmethcathinone completely co-elutes with 3-methylmethcathinone at 10 % modifier and 
above. The general trend with respect to modifier amount is that increased amount of modifier 
decreases retention time and produces narrower peaks. 
 
Figure 39. Gantt chart displaying the retention time for all the analytes of interest during isocratic elution on UHPSFC-




As few analytes are soluble in supercritical CO2 only, different organic solvents are often 
included. The organic solvent is often referred to as a modifier when added to the SFC mobile 
phase. Addition of modifier increases the solvating power of the mobile phase for better 




































solubility of polar analytes, by increasing the polarity of the mobile phase in SFC (see chapter 
2.4.4). Different modifiers are compatible with SFC conditions and provide a range of 
possibilities in optimizing the separation of analytes. In this thesis work methanol, ethanol and 
acetonitrile were tested as modifers. All modifiers were tested both with and without NH3 
additive, here shown with 40 mM NH3 and tested on the BEH column as it provided the best 
overall separation of the analytes of interest. Methanol was more extensively investigated 
with formic acid additive on the BEH column (data not shown) and different NH3 additive 
amounts as well (as shown in chapter 4.1.4).   
Methanol is by far the most commonly applied organic solvent used in SFC. It successfully 
makes the polar analytes solvable in the CO2 dominated mobile phase and avoids sample 
precipitation when it is introduced at the column inlet. It created satisfactory separation in the 
least amount of time of the modifiers evaluated in this thesis work (Figure 40). 
 
Figure 40. UHPSFC-MS/MS analysis of the analytes of interest on a UPC
2
 BEH column using 40mM NH3 in methanol as 
organic modifier. Chromatographic and MS conditions as described in chapter 3.1.1 and 3.2.1, respectively. Analytes 






The use of ethanol also showed satisfactory separation of the analytes, but with longer 
retention time compared to methanol. However, the equilibrium of ethanol is shifted slightly 
towards the hydroxylation of water, producing a solution at equilibrium which contains 96 % 
ethanol and 4 % water (Figure 41). This effect is caused by the high vapor pressure of pure 
ethanol, and thus a low boiling point, which means that ethanol molecules can evaporate into 
a gaseous state producing an azeotrope. The implication of the low boiling point is that the 
mixture equilibrates at a state of minimum 95.6 % by mass of ethanol in the mixture. This is 
indicated by the composition curve of ethanol and water having a minimum value lower than 
the boiling points of either of the pure components, a positive deviation from Raoult’s law 
commonly seen for such non-ideal mixtures of liquids. The effect of water in the mobile 
phase resulted in infrequent clogging of the system, which is further discussed in chapter 
4.3.2. 
 
Figure 41. UHPSFC-MS/MS analysis of the analytes of interest on a UPC
2
 BEH column using 40mM NH3 in ethanol as 
organic modifier. Chromatographic and MS conditions as described in chapter 3.1.1 and 3.2.1, respectively. Analytes 




Acetonitrile was also tested, but did not produce satisfactory results with the chosen stationary 
phase (Figure 42). It did, however, provide acceptable separation with the chiral column 
AMY1 (Figure 36). Acetonitrile was tested as an alternative to the alcohols, as it is classified 
as having different solvent selectivity according to Snyders triangle of solvents (Poole and 
Poole, 1991). The dissimilarity in selectivity behavior compared to the alcohols can be 
attributed to the higher dipole moment and less of proton acceptor ability of acetonitrile.  
 
Figure 42. UHPSFC-MS/MS analysis of the analytes of interest on a UPC
2
 BEH column using 40mM NH3 in acetonitrile as 
organic modifier. Chromatographic and MS conditions as described in chapter 3.1.1 and 3.2.1, respectively. Analytes 
from top to bottom: Methylmethcathinones (black), fluoromethamphetamines (purple) and fluoroamphetamines 
(green). 
Mixtures of the modifiers were also tested, at different proportion ratios, with all attainable 
stationary phases, gradients, isocratic elution, temperatures and pressures, but did not produce 
any improvement in chromatographic separation of the isomers of interest (data not shown). 
Methanol did produce a satisfactory separation with a reasonably short retention time for all 




of interest, with a somewhat longer runtime, but was discharged due to its inherent 
hygroscopic capability. The use of ethanol for this purpose would thus be quite expensive as it 
would require absolute ethanol (water-free). Acetonitrile did not produce satisfactory 





In this thesis work, NH3 was chosen as additive. NH3 is compatible with MS detection and 
increases the pH of the modifier sufficiently to compensate for the high pKa of the analytes. 
Formic acid was also tested in methanol modifier, but provided poor peak shapes as expected. 
An addition of 40 mM NH3 was required for satisfactory peak shape of the analytes, as shown 
in Figure 43.  
 
Figure 43. Aqueous NH3 used as additive and tested at different concentrations for UHPSFC-MS/MS analysis of the 
analytes of interest. Chromatographic and MS conditions as described in chapter 3.1.1 and 3.2.1, respectively. 
Methylmethcathinones (black), fluoromethamphetamines (purple) and fluoroamphetamines (green). 
The first NH3 additive tested was aqueous, meaning that water acted as a second additive in 
the mobile phase. Water has very low solubility in supercritical CO2 (~0.1 %, w/w), due to its 
high dipolar nature in contrast with the apolar CO2 (Tassaing et al., 2004; Oparin et al., 2005; 




CO2 when combined with an organic modifier. Water has twice the hydrogen bonding ability 
of methanol and becomes acidic in contact with CO2 (Figure 44). 
 
Figure 44. Equilibrium of water and CO2, creating carbonic acid (adapted from Nováková et al., 2014). 
The addition of water could improve the elution of polar analytes and is increasingly used as 
an alternative additive in SFC (Taylor, 2012; Lemasson et al., 2015a; Nováková et al., 2015; 
Pauk et al., 2015). However, the amount of aqueous NH3 additive needed to produce 
satisfactory peak shape for the analytes of interest, created frequent clogging due to CO2 
and/or water freezing in the instrument. Thus, no amount above 40 mM aqueous NH3 could 
be tested as it caused immediate clogging issues in the instrument. This occurrence was 
related to the amount of water added to the modifier and is discussed in chapter 4.3.2. 
Switching to a methanolic NH3 completely alleviated the problems of clogging. 
A methanolic NH3 additive was tested, to exclude the use of water in the SFC system. The 
NH3 additive was tested at concentrations greater than 40 mM as well. Nevertheless, 
concentrations greater than 40 mM did not produce improved peak shape, indicating that the 
system was saturated at 40 mM (Figure 45). Calculations of the additive proportions are 




Figure 45. Methanolic NH3 used as additive and tested at different concentrations for UHPSFC-MS/MS analysis of the 
analytes of interest.  Chromatographic and MS conditions as described in chapter 3.1.1 and 3.2.1, respectively. Analytes: 
Methylmethcathinones (black), fluoromethamphetamines (purple) and fluoroamphetamines (green). 
 
4.2.5 Column temperature 
 
The separation and behavior of the nine analytes were measured at different column 
temperatures and is displayed in Figure 46. The results of the analytes behavior at different 






Figure 46. Temperature effect; 40 – 50 – 60 – 70 °C. Chromatographic and MS conditions as described in chapter 3.1.1 
and 3.2.1, respectively. Analytes: Methylmethcathinones (black), fluoromethamphetamines (purple) and 
fluoroamphetamines (green). 
On a later time 80 °C was tested but showed poor separation for the fluoromethamphetamines 
with only two eluting peaks for the three isomers (data not shown). The three isomers of 
methylmethcathinone produced only two peaks at 40 °C and shows increasing enhancement 
in separation with increasing temperature. The best baseline separated was achieved at 80 °C 
for the methylmethcathinone isomers. The three isomers of fluoromethamphetamine on the 
other hand show complete baseline separation at 40 °C, and become less separated with 
increased temperature. The three isomers of fluoroamphetamine display satisfactory 
separation at all the temperatures tested.  The general trend seen in this thesis work is 
increasing temperature is related to a decrease in retention time, especially for the later eluting 
compounds. This is consistent with findings of other studies (West et al., 2012b). According 
to the group of Nováková, this initial retention decrease is due to a reduction in mobile phase 
density. After reaching a maximum, the retention decreases at very high temperatures. As 
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temperature affects the solubility parameters of both the solute and the mobile phase, it may 
also alter the affinity of the analyte towards the stationary phase (Nováková et al., 2014). 
Thus, the effect of temperature on the retention of analytes in SFC is complicated 
combination of various mechanisms, which can be difficult to explain and interpret. Another 
interesting aspect of SFC during gradient elution is that decompression cooling may occur due 
to increasing modifier proportion in the mobile phase (Pauw et al., 2014). This was not noted 
in the current thesis work.  
The temperature chosen for this method was 60 °C, as it produced three symmetrical peaks 
for all the analytes of interest.  
4.2.6 Back pressure 
 
The separation and behavior of the nine analytes were measured at different back pressures 
and is displayed in Figure 47. 
 
 
Figure 47. Effect of pressure measured for the analytes of interest;  1600, 1700,  1900, 2200 psi. The supplementary 
Chromatographic and MS conditions as described in chapter 3.1.1 and 3.2.1, respectively. Analytes: 




Increasing the pressure resulted in decreased retention time for all analytes. This is a result of 
increased density of the mobile phase resulting in increased elution power. Nevertheless, an 
additional unexpected effect was seen with increased pressure above 1800 psi; the peaks 
became jagged and uneven. This phenomenon is described in chapter 4.3.1. In an attempt to 
avoid poor peak shape caused by too high back pressure, 1800 psi was chosen for this 
method. Lower back pressures were also considered, but were omitted in favor of the highest 
attainable pressure with satisfactory peak shape due to a wish for the mobile phase to be as 
homogeneous as possible.  
Mixing the supercritical CO2 with the methanolic modifier will change the physical properties 
of the fluid and require higher temperature and pressure to attain supercritical features of the 
fluid (described in chapter 2.3.4). Evaluating the homogeneity of the mobile phase in SFC is 
difficult, but as the analytes of interest elute at small modifier percentages there might be 
reasonable homogeneity at the chromatographic settings chosen for this method. 
4.2.7 Sample solvents  
 
For proper analysis, the sample solvent should dissolve in the SFC mobile phase without 
affecting sample retention or resolution and be compatible with the detection device. Ideally 
the sample solvent should be the same as the mobile phase, but in the case of SFC dissolving 
analytes in supercritical CO2 in a vial would be challenging.   
The six solvents tested (Figure 48) were chosen based on sample solubility and the elutropic 
properties on bare silica (Poole and Poole, 1991; Fountain et al., 2014). The ideal sample 
solvent is a trade-off between solubility in the relatively apolar mobile phase of SFC and the 
solubility of the polar analytes to achieve optimal peak shape. It should also be noted that 
volatile solvents can evaporate in the vials, leading to a continuous concentration of the 
sample over time. Nonpolar solvents such as hexane and heptane are best compatible with the 
mobile phase, but the analytes in this thesis work are quite polar and thus more soluble in 
polar solvents (Iraneta et al., 2013). Regarding the MS detection, the sample solvent should 






Figure 48. A: H2O; B 50:50 H2O and methanol C: Ethanol; D: Methanol E: Isopropanol. Chromatographic and MS 
conditions as described in chapter 3.1.1 and 3.2.1, respectively. Analytes: Methylmethcathinones (black), 
fluoromethamphetamines (purple) and fluoroamphetamines (green). 
Isopropanol produced satisfactory peaks for all the analytes of interest (Figure 48E). 
Methanol showed poorer peak shape (Figure 48D), probably due to its higher eluotropic 
value, while the slightly weaker eluent ethanol produced quite good peak shape (Figure 48C). 
However, it should be noted that the ethanol mixture probably contained about 4 % water as 
well. Although ethanol provided excellent peak shape, it was not chosen due to the wish for 
exclusion of any water from the instrument. 
Mixing water and methanol provided quite poor peak shape (Figure 48B), whereas water 
varyingly produced good peak shape, but also highly inadequate chromatograms (Figure 
48A). This is probably a result of the inherent immiscibility of water in the CO2-dominant 





Figure 49. Poor chromatogram as a result of using water as sample solvent Chromatographic and MS conditions as 
described in chapter 3.1.1 and 3.2.1, respectively. Analytes from top to bottom: Methylmethcathinones (black), 
fluoromethamphetamines (purple) and fluoroamphetamines (green). 
 
A mix of heptane and isopropanol was also tested (90:10), but did not provide any 
improvement in the chromatographic peak shape compared to isopropanol (data not shown). 
As it offered no advantage, it was excluded due to a somewhat more time consuming sample 
work up.  
The differences in the results of the tested sample solvents could be caused by the contrasting 
elution strength of the solvents and viscous fingering effects (Abrahamson and Sandahl, 2013; 
Enmark et al., 2015).  Isopropanol was chosen as a sample solvent as it provided satisfactory 
peak shape and provided easy sample dissolution.  
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4.2.8 Summary  
 
The chosen settings for this method became a sample preparation consisted of LLE using 
ethylacetate:heptane (80:20, v/v). After evaporation, the samples were reconstituted in 
isopropanol before injection. Four 
13
C6-labelled analogs were used as ISs (chapter 3.5, Figure 
25). The preferred stationary phase was an ethylene-bridged hybrid (BEH) column (3 mm x 
100 mm, 1.7 µm), using a flow rate of 2 mL/min, 1800 psi in back pressure, and gradient 
elution with 40 mM ammonia in methanol and supercritical CO2. The injected volume was 
0.5 µL. Quantification was performed by tandem MS using multiple reaction monitoring 
(MRM) in positive mode, applying two transitions for the compounds and the IS. The run 
time for the method was 4 min. 
Although the chosen conditions initially produced satisfactory separation for all nine analytes 
of interest, there was an alteration in the stationary phase chemistry which became apparent 
over time. This was seen as a retention time and the baseline separation decreased for all the 
analytes. This effect is more extensively discussed in chapter 4.3.3. 
Nevertheless, this effect became especially apparent for the methylmethcathinone analytes 
which became impossible to separate on the degraded stationary phase. A regeneration regime 
was designed and produced only temporarily satisfactory results for the methylmethcathinone 
analytes. As it was not possible to validate the method for the methylmethcathinone analytes, 






4.3 Technical challenges 
 
Although many of the former difficulties of applying SFC have been reasonably resolved, 
there also appeared a couple of new challenges. The challenges encountered in this thesis 
work will be somewhat elaborated on in this chapter.  
 
4.3.1 Spray pulsing 
 
During the work of evaluating the optimal pressure 
for this method, a surprising phenomenon occurred 
in the chromatograms. As the pressure was 
increased the peaks became increasingly degraded 
as shown in Figure 47, chapter 4.2.6, and Figure 50. 
During the troubleshooting process, it was 
discovered that the spray flowing into the ESI 
appeared to be pulsating.  
Figure 50. Degraded peak due to spray pulsing (Fogwill, 2015).  
Spray pulsing or poor spray stability is a phenomenon that occurs with SFC-MS, likely a 
result of the transition between high and atmospheric pressure at the interface of the UHPSFC 
and MS detector. The SFC-MS interface consists of a split 
restrictor and a makeup pump, as shown in Figure 20 and 21 
(chapter 3.1). The split restrictor (Figure 51) has the function 
of splitting the flow between going to the MS and the back 
pressure regulator. The split ratio is the ratio of mobile phase 
flow directed to the MS and to the BPR. According to Waters 
co., a large split ratio (i.e. 10:1) means that a small portion of 
the total flow rate is directed to the MS, whereas a small split 
ratio (i.e. 2:1) entails that a larger portion of the mobile phase 
flow is directed to the MS. The size of the split ratio is 
governed by the flow speed and BPR. The makeup pump 
functions in 
Figure 51. Schematic diagram of the split restrictor (Fogwill, 2015). 
84 
 
 accordance with the split restrictor and has a multitude of functions. The makeup flow aids 
the transport of analytes trough the split restrictor, restrictor and probe, provides flow to the 
back pressure regulator in order to appropriately adjust the back pressure, and introduces 
ionization-enhancing compounds to the MS to increase ionization efficiency.  
High pressure in the system, allows alcohols and other fluids to be at least partially solved in 
the supercritical CO2. However, when the pressure decreases the solvation power of the CO2 
also decreases as it transitions towards gaseous phase. 
The spray pulsing occurs as a result of the more or less homogenous mobile phase being 
decompressed along the length of the split restrictor as the pressure decreases towards 
atmospheric pressure (Figure 52). As the density drops, the CO2 gradually loses its miscibility 
with the co-solvent. At the outlet of the split restrictor, there is complete phase separation 
between the liquid co—solvent and the gaseous CO2, where the co-solvent coalesce 
into/forms droplets. These droplets are pushed through the probe by gaseous CO2, producing 
the pulsing spray into the MS (Fogwill, Waters).  
 
Figure 52. The phase separation that occurs in the split restrictor (adapted from figure of Michael Fogwill, Waters) 
There are no published studies so far on the phenomenon of spray pulsing at the interface of 
SFC and MS. The phenomenon was presented on a Waters conference for UPC
2
 users in 
Gothenburg, Sweden, in May of 2015. However, the group of Lesellier et al. recently 
published a study on the optimization of the mobile phase composition of SFC for drug 
analysis. When comparing of the effect of different additives, an unexpected poor result was 
obtained for ammonium formate. As a volatile salt, it has often been recommended in SFC-
MS studies. The group concluded that the surprising result was most likely a result of 
clogging at the interface of the SFC and MS (Lemasson et al., 2015a). As the mobile phase is 




expansion of the CO2 thus occurs at the split restrictor and beyond, which could result in the 
formation of CO2 ice particles at the interface of the SFC instrument and the MS. 
 
4.3.2 Effect of water in the UHPSFC system 
 
During this thesis work, both aqueous and methanolic NH3 was tested as additives, and the 
use of aqueous NH3 lead to extensive problems with clogging of the system, probably due to 
the formation of CO2 ice particles. Apparent CO2 ice formation was distinguished by that the 
clogged instrumental parts felt cold and flow passage was found to be strenuous or impossible 
at the particular site during troubleshooting. A possible explanation of why this occurs more 
frequently when using aqueous NH3could be related to the fact that the system has difficulties 
with producing a miscible and homogenous mobile phase when a fourth compound is added. 
Additionally, the difference in polarity between CO2 and water might also be the cause of 
clogging within the system as it affects the miscibility in the apolar CO2.The clogging 
apparently occurred at several locations in the instrument (as tested by unscrewing the 
instrument and running flow through it, feeling for cold patches etc. in collaboration with a 
Waters co. technician).  
However, when the NH3 solution used was replaced with an NH3 solution in methanol 
clogging was no longer an issue. The clues as to how this could occur were provided when 
testing different percentages of NH3 on the system. 13 and 26 mM (0.1 and 0.2 %) was 
unproblematic. Mostly nice chromatograms were produced with 40 mM (0.3 %), but also 
regular “downtime” due to clogging and subsequent pressure problems. A concentration of 53 
mM (0.4 %) of aqueous NH3 additive was never possible to achieve, only a single run could 
sometimes be performed with such a solution. The pressure would suddenly increase rapidly 
and cause the system to stop the flow as it passed the maximum pressure of 6000 psi. This 
effect occurred most frequently at high modifier percentage, which made a new hypothesis 
occur; that this effect was caused by the NH3 additive, water or the combination of both?  
In an attempt to answer the hypothesis, an NH3 additive dissolved in methanol was tested, to 
alleviate water from the system. Any NH3 amount tested with the methanolic NH3 solution, 
even at concentrations higher than 53 mM (0.4 %) could be used without any clogging 
occurring. This lead to the conclusion that it was probably the water in the modifier solution 
that caused the infrequent clogging problems. Water was also added to the modifier solution 
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with the NH3 solved in methanol, at the same amount as in the aqueous NH3modifier, which 
produced the same clogging problems as seen with the aqueous NH3 (calculations shown in 
Appendix II, data not shown). 
Water did not appear to have significant effect on the separation of the analytes of interest, as 
the water-free modifier produced comparable chromatograms as shown in Figure 53. 
However, the retention time of the analytes was affected by the removal of water, which is 
further discussed in chapter 4.3.3. 
 
 
Figure 53. UHPSFC-MS/MS analysis of the nine analytes of interest using a) 40 mM aqueous NH3 in methanol and b) 40 
mM NH3  in methanol. 
The study of Tassaing et al., 2004 concerning the miscibility of water in supercritical CO2 
gives good insight into the reasons why even small amounts of water in this SFC instrument 
causes clogging and pressure problems. Considering that supercritical CO2 is not miscible 
with water at nearly any amount at the conditions attainable with the SFC instrument from 
Waters co., it is reasonable to assume that even small amounts of water causes inconsistent 
pressure due to clogging problems. The SFC instrument from Waters can attain a maximum 
temperature and pressure of 90 °C and 5800 psi (400 bar). However, due to gradient elution 
being the most optimal method of choice a lower BPR pressure must be chosen as higher 
modifier percentage causes a proportional increase in pressure (modifier gradient causes 




would have settings of maximum 80 °C and 2600 psi (180 bar). Nevertheless, in order for a 
small percentage water (up to 5 %, w/w) to exist in a dimer, creating a partially mixed phase 
with supercritical CO2, the minimum conditions would have to be at least 100 °C and 2900 
psi (200 bar). In order to create a total miscibility, where there are only dimers detected in 
CO2, conditions of minimum 360 °C and 2900 psi (200 bar) must be attained (Figure 54). 
 
Figure 54. Phase diagram of the H2O/CO2 mixture at constant pressure. Insert: Concentration of water dissolved in CO2 
and density of the CO2 rich phase as a function of the temperature at constant pressure, P=250 bar (Tassaing et al., 2004). 
Additionally, even with an instrument which could attain high enough temperature and 
pressure other issues would occur. Supercritical water is highly corrosive and would demand 
corrosion resistant alloys like austenitic stainless steel, made of alloys with high amounts of 
chromium and nickel (Kritzer, 2004; Marrone and Hong, 2009). Additionally, the compounds 
to be analysed must withstand the oxidative properties of supercritical water.  
What happens inside the SFC instrument is difficult to elaborate on, but as water is 
immiscible with the CO2 rich mobile phase it forms droplets which could obstruct the passage 
of the supercritical CO2. The unsteady flow could cause occasional expansion of CO2, and as 
the system is well isolated the process would be adiabatic. The expanding fluid would thus 




4.3.3 Evaluation of retention drift  
 
The BEH column showed a superior separation compared to the other stationary phase 
chemistries tested in this thesis work. However, after repeated injections the BEH-column 
displayed a high degree of decrease in retention time and poor separation between the 
positional isomers. This retention drift was also observed in two of the Torus columns; 2-PIC 
and DEA. Nevertheless, as these columns where not chosen for this method they were not 
investigated as meticulous as the BEH column and no certain conclusion can be drawn. No 
conclusion can be made about the robustness of the 1-AA or AMY1 columns, as they were 
tested only once at an external laboratory and due to a restricted time schedule, respectively.  
The problem was not apparent at first. It was recently discovered to happen very quickly 
under the water-free conditions chosen for this method. At first an aqueous NH3 solution was 
used as an additive. Although the small amount of water in this solution caused clogging 
issues, it probably has somewhat inhibited the effect of retention drift. Switching to a 
methanolic NH3 solution completely solved the problems of clogging. Nevertheless, it also 
resulted in a pronounced retention drift in the system with use; the retention time decreased 
significantly, especially for the later eluting compounds. Additionally, the separation and in 
particular the baseline separation between the analytes were significantly decreased after a 
few hundred injections, in particular for the methylmethcathinones eluting at lower modifier 
percentages as shown in Figure 55.  
 
Figure 55. Using a 
methanolic NH3 additive 
lead to a rapid retention 
drift and decreased baseline 
separation of the nine 
analytes of interest using 
the BEH column in the 
UHPSFC-MS/MS system.  a) 
After 2 injections on a new 
BEH column. b): After 400 
injections on the same BEH 









Explaining the cause of this effect is risky, as no specific experiments were made to further 
investigate this effect. Rather, the effect was observed and possible causes are considered.  
Considering the chemistry of the BEH column as consisting of particles with mainly 
unbounded silanol seats on its surface, there is a single source of retention on the stationary 
phase. When assuming no change in other chromatographic conditions, any retention change 
can be correlated to a modification of the silica surface (Fairchild et al., 2015).  
Many papers have been published on the adsorption of modifier onto stationary phases in 
chromatographic systems, especially in SFC, possibly explaining the chromatographic 
changes (Jinno and Niimi, 1988; Janssen et al., 1989; Strubinger et al., 1991b; Heaton et al., 
1994; Gurdale et al., 2000; Lesellier et al., 2002; Smuts et al., 2011; Vajda and Guiochon, 
2013; Lesellier and West, 2015). Nonetheless, Fairchild and colleagues have suggested that 
this retention drift is caused by a silyl ether formation when using methanol as a modifier in 
an SFC system on a silica-based stationary phase (Figure 56) (Fairchild et al., 2015). This has 
also been proposed in earlier years by other groups (Hirata and Nakata, 1984; Schmitz et al., 
1987). 
 
Figure 56. Silyl ether formation as proposed by Fairchild et al. to occur in typical SFC conditions when using silica-based 
stationary phase like the BEH column and methanol as a modifier (adapted from Fairchild et al., 2015). 
Both of these effects are indicative of a higher modifier proportion. It is already known that 
modifier adsorption occurs in chromatographic systems using a Lewis acid (electron pair 
acceptor, electrophile) mobile phase in combination with a Lewis base (electron pair donor, 
nucleophile) stationary phase, such as methanol on a silica support. This effect has been 
proven in several studies, observed in both LC and SFC systems (Scott and Kucera, 1978; 
Janssen et al., 1989; Lesellier and West, 2015). However, it is more pronounced in SFC 
systems due to the apolar nature of CO2, which probably accelerates the retention drift when 
combined with the polar methanol modifier and NH3 additive. The apolar nature of CO2 
makes it repulse the polar counterparts. The inherent immiscibility of water in supercritical 
CO2 under the conditions applied in this system adds to the retention drift, as only miniscule 
amounts of water can be added to mitigate this effect. In SFC systems both CO2 and methanol 
can be prone to adsorption onto the stationary phase. However, adsorption of CO2 is favored 
on octadecylsilane (ODS) stationary phases, while the adsorption of methanol is higher onto 
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silica stationary phases (Janssen et al., 1989; Strubinger et al., 1991a and b; Heaton et al., 
1994; Gurdale et al., 2000; Lesellier et al., 2002; Lesellier and West, 2015). The mobile phase 
in this thesis work is also added a basic NH3 additive. The NH3 molecule having a significant 
dipolar moment makes it another possible influence on the chemistry of the stationary phase, 
by hydrogen bonding to the silanol seats of the BEH particles and/or by acting as a catalyst of 
adsorption of modifier or of silyl ether formation.  
A study by West and Lesellier (2013) showed that the mobile phase components adsorb on 
the stationary phase surface in such a manner that the modifier proportion in this layer of 
adsorbed mobile phase components is much larger than in the bulk mobile phase. A study 
indicated that the adsorbed layer was nearly 25 % methanol when the mobile phase only 
contained 2 % methanol (Strubinger et al., 1991). The modifier is likely to adsorb onto the 
stationary phase by alcohol condensation. Two factors accelerates this process in the 
UHPSFC-system; 1) The apolar nature of the super-/subcritical CO2 drives the polar solutes to 
interact more with the polar seats at the stationary phase. 2) The silyl ether formation is base 
catalyzed. The conditions chosen as the best for the separation of the analytes in question 
entails a relatively high dose of alkaline additive of 40 mM NH3 in the modifier flask. In 
comparison; the recommended maximum dose from the supplier is 20 mM NH3 added in the 
modifier bottle. 
Some studies have compared the behavior of the most commonly applied modifiers; 
methanol, ethanol and isopropanol (Strubinger et al., 1991b; Vajda and Guiochon, 2013; West 
and Lesellier, 2013). They have indicated that the slower adsorption of ethanol versus 
methanol might be a result of the reaction kinetics expected to be significantly lower for the 
formation of longer alkyl chain silyl ethers. Longer hydrocarbon chain makes the ethanol 
molecule less polar compared to the methanol molecule, making it a poorer nucleophile and 
possibly causing steric hindrance. Therefore the modifier adsorption or silyl ether formation 
of ethanol is proposed to be many times slower than with methanol. Based on the indications 
made by Strubinger et al.  (1991b)and their own observations, West and Lesellier (2013) 
suggested that the observed surprising behavior of methanol versus ethanol might result from 
different aggregation of alcohol molecules on the stationary phase, which might induce 
different surface chemistry. The conformational arrangement of the solvated selector might be 
different, but also the overall composition of the layer of adsorbed mobile phase components 




However, when ethanol was applied as a modifier clogging problems eventually occurred 
with a solution older than a few hours due to the equilibria of ethanol being shifted slightly 
towards the hydroxylation of water, producing a solution which contains about 4 % water. 
Fairchild proposed to use 5 % water in the modifier solution to compensate for the use of NH3 
(Fairchild et al., 2015). However, the use of smaller amounts of water has been problematical 
in this thesis work especially in repeated injections.  
Furthermore, Fairchild et al. (2015) demonstrated that a washing regime using pure distilled 
water could mitigate the proposed silyl ether formation according to proposed equilibrium 
(Figure 54) and the principle of Le Chatelier. A similar washing regime was tested to attempt 
to regenerate the BEH column. The result was a partially restored BEH column, but no 
complete regeneration was attained (data not shown/details in Appendix VI). The degradation 
of the column occurred more rapidly with the regenerated columns than with unused columns. 
So, although the chosen conditions initially produced satisfactory separation for all nine 
analytes of interest, there was an alteration in the stationary phase chemistry which became 
apparent over time. This phenomenon affected the analytes differently; the methyl group 
found on C1 of the common structure in methamphetamine, fluoromethamphetamine and 
methylmethcathinone appeared to make the analytes somewhat more robust for these 
chromatographic changes, but the reason for this effect is not known. Conversely, this effect 
became especially apparent for the methylmethcathinone analytes, which became impossible 
to separate on the degraded stationary phase as shown in Figure 53. The regeneration regime 
tested produced only temporarily satisfactory results for the methylmethcathinone analytes, 
only attainable for the first few injections. As a result it was not possible to validate the 
method for the methylmethcathinone analytes, and they were excluded from the validation 
procedure.  
A possible reason as to why the methylmethcathinones analytes are more sensitive for the 
chromatographic alterations in the column could lie in the molecular structure. Structural 
studies have indicated that methylmethcathinones are considerably more hydrophilic than 
methylamphetamines and that the ketone group in the side chain contributes to far more 
planar structure (Gibbons and Zloh, 2010; Kelly et al., 2011). The other 2-, 3-, 4-positional 
isomers have in common that they have a fluor atom on the phenyl ring. Fluor being the most 
electronegative atom could give the analytes containing such a nucleophile a higher affinity 
for the polar seats in the BEH stationary phase compared to methylmethcathinone. Thus, the 
methylmethcathinone molecules are successfully separated on a BEH stationary phase, but 
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they are more sensitive to the covering of the silanol seats by modifier or the NH3 additive 





4.4 Method validation  
 
Method validation was performed to confirm that this analytical procedure is suitable for its 
intended use. The data obtained is used to evaluate the quality, reliability and consistency of 
the method. All validation parameters were executed in concordance with the validation 
regime of NIPH and by using spiked blood samples. All calculations were performed using 
Microsoft Excel software. 
 
4.4.1 Interday precision and accuracy 
 
The results for interday precision and accuracy (Table 12 and 13) were considered to be 
satisfactory for this method, as relative stand deviation (RSD) was below 15 % for all analytes 
above their respective LOQ. The classical phenethylamines displayed a precision below 10 % 
for all the levels above the LOQ. Accuracy was below 20 % for all the 2-, 3-, 4-
phenethylamines for the levels above LOQ, while the classical phenethylamines demonstrated 
an accuracy below 10 % at all levels. However, the accuracy was below 3 % for most of the 
levels. 
For the concentration levels below LOQ there was poor precision and accuracy, as expected. 
The complete data set for the between-series measurements of precision and accuracy can be 















Precision      
Analyte   (RSD, %)     
2-fluoroamphetamine       
    0.0050       0.0044     -12   32         
  0.010   0.0094     -6.2   24         
  0.10   0.11     9.3   8.2         
  1.0   1.1     7.8   8.5         
  5.0   5.4     7.4   7.4         
  10   10     1.8   8.3         
3-fluoroamphetamine                         
    0.0050       0.0042     -17   35         
  0.010   0.01     0.61   22         
  0.10   0.11     5.7   16         
  1.0   1.2     16   6.4         
  5.0   5.7     12   12         
  10   10     4.4   7.1         
4-fluoroamphetamine                         
    0.0050       0.0046     -9.5   40         
  0.010   0.01     -4.5   46         
  0.10   0.11     13   14         
  1.0   1.1     13   6.6         
  5.0   5.6     11   12         
  10   9.8     -2.8   2.7         
2-fluoromethamphetamine                         
    0.0050       0.0053     3.8   49 
 
      
  0.010   0.01     1.2   17         
  0.10   0.12     22   15         
  1.0   1.2     18   7.5         
  5.0   5.6     11   8.2         
  10   11     5.2   6.4         
3-fluoromethamphetamine                         
    0.0050       0.0067     31   71         
  0.010   0.011     12   32         
  0.10   0.12     19   15         
  1.0   1.2     18   8.5         
  5.0   5.6     10   5.4         
  10   11     9   5.8         
4-fluoromethamphetamine                         
    0.0050       0.012     140   44 
 
      
  0.010   0.014     45   30         
  0.10   0.11     12   8.9         
  1.0   1.1     11   6.1         
  5.0   5.2     3.1   12         
  10   10     0.36   4.2         




Table 13. Interday precision and accuracy of the classical phenethylamines.* 
  
   n=8 
  
    
  Concentration 
(µM) 





      
Analyte         
                          
Amphetamine                     
  0.0050     0.0070     41 46   
  0.010   0.011     8.4   19   
  0.10   0.10     2.3   5.4   
  1.0   1.0     -0.76   9.2   
  5.0   5.0     -0.76   5.6   
  10   10     0.69   3.7   
                    
                    
Methamphetamine                 
  0.0050     0.0060     20 34 
   0.010   0.010     -2.1   13   
  0.10   0.10     2.2   5.4   
  1.0   1.1     9.1   17   
  5.0   5.1     2.3   5.1   
  10   10     3.1   3.5   
                    
MDMA                   
  0.0050     0.0074     45   50   
  0.010   0.010     -0.35   24   
  0.10   0.10     -0.91   6.5   
  1.0   1.0     -0.84   6.2   
  5.0   4.9     -2.2   5.6   
  10   9.9     -2.4   5.9       
*The dotted line indicates LOQ. 
 
4.4.2 Intraday precision and accuracy 
 
Precision was below 15 % for all analytes at the levels above LOQ. Accuracy given as bias 
was calculated as the percent deviation of the measured mean of the QC samples from the 
nominal concentration. Accuracy was +/- 20 % from the true value for most analytes, given as 
a bias where 0 % indicates perfect accuracy. For the lowest concentrations of 4-
fluormethamphetamine and amphetamine, poor accuracy was obtained with a calculated 
concentration that was close to three times as large as the theoretical value. However, as this 
is below LOQ it will not affect the reliability of the results provided to the consignors. The 
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accuracy and precision of the classical phenethylamines was generally higher than that of the 
2-, 3-, 4-phenethylamines, probably due to the use of analogue isotope labelled ISs. All 
accuracy and precision data are summarized in Table 14 and 15. The complete dataset for the 
intraday precision and accuracy experiment is shown in Appendix VII. 
 
Table 14. Intraday precision and accuracy for the 2-, 3-, 4-phenethylamines.* 








µM µM µM % % 
0.01 0.0082 0.0019 23 -18 
0.1 0.11 0.015 14 10 
1.0 1.2 0.15 12 20 
5.0 6.1 0.51 8.3 21 
10  11 0.88 7.6 16 
 
 









µM µM % % 
0.01 0.0091 0.00085 9.4 -9 
0.1 0.11 0.012 10 15 
1.0 1.2 0.073 5.9 23 
5.0 6.6 0.39 6.0 30 













µM µM % % 
0.01 0.0078 0.00089 11.5 -22 
0.1 0.12 0.0078 6.6 17 
1.0 1.29 0.056 4.3 27 
5.0 6.2 0.57 9.3 22 

















µM µM % % 
0.01 0.012 0.0015 12.3 25 
0.1 0.13 0.0171 13.2 29 
1.0 1.2 0.074 6.1 21 
5.0 5.8 0.42 7.2 16 
10  11 0.57 5.1 11 
 
 









µM µM % % 
0.01 0.011 0.0013 11.7 11 
0.1 0.13 0.0034 2.6 31 
1.0 1.2 0.065 5.5 17 
5.0 5.9 0.34 5.7 17 
10  11 0.73 6.6 10 
 









µM µM % % 
0.01 0.029 0.0011 3.8 187 
0.1 0.13 0.0072 5.5 30 
1.0 1.2 0.060 5.2 16 
5.0 5.9 0.29 5 16 
10  11 0.36 3.2 11 
     





Table 15. Intraday precision and accuracy for the classical phenethylamines.* 
  
 









µM µM % % 
0.01 0.031 0.0085 28 210 
0.1 0.11 0.0063 5.8 6.4 
1.0 1.0 0.050 5.0 2.3 
5.0 4.9 0.18 3.7 -2.3 
10  10 0.37 3.6 1.0 
 
 









µM µM % % 
0.01 0.0092 0.0013 14 -8.3 
0.1 0.095 0.0055 5.8 -4.9 
1.0 1.0 0.037 3.6 3.4 
5.0 5.1 0.14 2.7 1.7 













µM µM % % 
0.01 0.0094 0.00053 5.7 -6.2 
0.1 0.099 0.0024 2.4 -0.83 
1.0 1.0 0.030 2.9 2.4 
5.0 5.0 0.099 1.5 -1.0 
10  10 0.18 1.8 1.6 
         





4.4.3 Linearity  
 
In order to evaluate the linearity of the method the calibration curves were produced, based on 
one parallel of each of the eight calibrators. Linear calibration curves with R
2
 ≥ 0.99 were 
achieved for all analytes using a weighted (1/x) linear calibration curve and including the 
origin. Eight calibrators were used to measure linearity of the method, but on a routine basis 
only five calibrators are used. Linearity was measured with extracted samples with a 
concentration of 0.001, 0.005, 0.010, 0.100, 1.00, 2.00, 4.00, 6.00, 8.00 and 10.00 µM. The 
results are shown in Table 16, while the linearity graphs are shown in Appendix VII. 
The standard curves for the 2-, 3-, 4-isomers were slightly flattening at high concentrations, 
indicating that an incomplete ionization occurs in the ESI. This effect could be alleviated with 
the use of specific ISs and/or by the use of a quadratic standard curve. Quadratic standard 
curves were tested and produced good correlation of the lowest concentrations, but poorly 
described the concentration of the high samples.  
 
Table 16. Data from the linearity experiment. 








C6-PMMA 1/x-weighting 0.001 – 10  0.9939 
3-fluoroamphetamine 
13
C6-PMMA 1/x-weighting 0.001 – 10  0.9971 
4-fluoroamphetamine 
13
C6-PMMA 1/x-weighting 0.001 – 10  0.9959 
2-fluoromethamphetamine 
13
C6-PMMA 1/x-weighting 0.001 – 10  0.9917 
3-fluoromethamphetamine 
13
C6-PMMA 1/x-weighting 0.001 – 10  0.9940 
4-fluoromethamphetamine 
13
C6-PMMA 1/x-weighting 0.001 – 10  0.9929 
Amphetamine 
13
C6-amphetamine 1/x-weighting 0.001 – 10  0.9976 
Methamphetamine 
13
C6-methamphetamine 1/x-weighting 0.001 – 10  0.9867 
MDMA 
13




4.4.4 Limit of detection and limit of quantification  
 
The calculated LOD and LOQ are within expected values for similar compounds analysed 
with UHPLC at NIPH. The LOD varied from 0.007 to 0.02 µM for all analytes. The LOQ 
varied from 0.02 to 0.06 µM for all analytes. The results for LOD and LOQ are shown in 
Table 17. 
Table 17. LOD* and LOQ** for the 2-, 3-, 4-isomers. 
  
     LOD (µM)     LOQ (µM)       
2-fluoroamphetamine     0.0067     0.017       
3-fluoroamphetamine     0.0068     0.017       
4-fluoroamphetamine     0.011     0.024       
2-fluoromethamphetamine     0.010     0.029       
3-fluoromethamphetamine     0.019     0.052       
4-fluoromethamphetamine     0.024     0.061       
Amphetamine     0.013     0.036     
Methamphetamine     0.0076     0.022     
MDMA     0.014     0.039     
*  LOD is calculated based on the formula: LOD = mean blank + 3SD control 0.005 µM     
 
** LOQ is calculated based on the formula: LOQ = mean blank + 10SD control 0.005 µM     
 
4.4.5 Matrix effect 
 
ME was measured at two different concentration levels and with two different injection 
volumes, as displayed in Table 18 – 21. The contribution of ME is considered acceptable 
between 75 and 125 %, with RSDs ≤ 25 % when using deuterated ISs (Paul et al., 2009). MEs 
were between 67 and 81 % for all the 2-, 3-, 4-isomers with RSDs between 15 and 22 %, 
while the classical phenethylamines experienced between 88 and 93 % ME with RSDs 
between 3.8 and 8.2 %. This suggests that the analytes experiences ion suppression. However, 
it should be noted that MEs were overall low for most analytes. The poor correction of ME by 
the ISs for some of the analytes could be due to the calculations being based on concentration, 
rather than on peak height. The 2-, 3-, 4-isomers had high RSDs which might have been 
possible to correct with an isotope-labelled analogue IS, but no commercial 
13
C6-labelled or 
deuterated analogue IS was currently available for all the isomers. ME was also tested at 2.0 
µL injection with the same concentration levels. ME ranged between 85 and 102 % for all the 
2-, 3-, 4-isomers with RSDs between 10 and 20 %, while the classical phenethylamines 





Table 18. Data for matrix effect experiment of 0.1 µM samples with 0.5 µL injection.* 
 
  
  0.1µM, n=10 
Substance ME corrected RSD ME RSD 
2-fluoroamphetamine 93 % 14 % 112 % 7.3 % 
3-fluoroamphetamine 85 % 13 % 103 % 7.0 % 
4-fluoroamphetamine 102 % 20 % 123 % 15 % 
2-fluoromethamphetamine 99 % 13 % 119 % 5.0 % 
3-fluoromethamphetamine 93 % 10 % 112 % 6.6 % 
4-fluoromethamphetamine 94 % 16 % 113 % 5.6 % 
Amphetamine 76 % 10 % 98 % 6.5 % 
Methamphetamine 73 % 3.0 % 106 % 6.3 % 
MDMA 70 % 4.9 % 106 % 5.5 % 
*Matrix effect was measured with two parallels and five different lots of blank blood. 
 
Table 19. Data for matrix effect experiment of 1.0 µM samples with 0.5 µL injection.* 
 
 
    1µM, n=10 
Substance ME corrected RSD ME RSD 
2-fluoroamphetamine 81 % 22 % 95 % 16 % 
3-fluoroamphetamine 67 % 17 % 79 % 14 % 
4-fluoroamphetamine 77 % 19 % 90 % 16 % 
2-fluoromethamphetamine 78 % 17 % 92 % 14 % 
3-fluoromethamphetamine 70 % 19 % 82 % 15 % 
4-fluoromethamphetamine 72 % 15 % 85 % 9.2 % 
Amphetamine 89 % 8.2 % 84 % 4.4 % 
Methamphetamine 93 % 5.6 % 96 % 2.7 % 
MDMA 91 % 3.8 % 105 % 3.1 % 





Table 20. Data for matrix effect experiment of 0.1 µM samples with 2.0 µL injection.* 
 
  
  (0.1µM, n=10) 
Substance ME corrected RSD ME RSD 
2-fluoroamphetamine 98 % 7.9 % 94 % 7.5 % 
3-fluoroamphetamine 97 % 9.2 % 93 % 6.9 % 
4-fluoroamphetamine 111 % 6.5 % 107 % 2.9 % 
2-fluoromethamphetamine 101 % 8.1 % 96 % 5.8 % 
3-fluoromethamphetamine 104 % 7.2 % 99 % 3.6 % 
4-fluoromethamphetamine 97 % 7.6 % 93 % 3.7 % 
Amphetamine 79 % 8.4 % 60 % 13 % 
Methamphetamine 75 % 4.3 % 68 % 8.4 % 
MDMA 73 % 3.8 % 77 % 4.8 % 
*Matrix effect was measured with two parallels and five different lots of blank blood. 
 
Table 21. Data for matrix effect experiment of 1.0 µM samples with 2.0 µL injection.* 
 
  
  (1.0 µM, n=10) 
Substance ME corrected RSD ME RSD 
2-fluoroamphetamine 81 % 22 % 95 % 16 % 
3-fluoroamphetamine 67 % 17 % 79 % 14 % 
4-fluoroamphetamine 77 % 19 % 90 % 13 % 
2-fluoromethamphetamine 78 % 17 % 92 % 13 % 
3-fluoromethamphetamine 70 % 19 % 82 % 16 % 
4-fluoromethamphetamine 72 % 15 % 85 % 9.7 % 
Amphetamine 95 % 4.3 % 60 % 4.9 % 
Methamphetamine 93 % 4.9 % 70 % 4.7 % 
MDMA 87 % 4.7 % 80 % 4.2 % 





4.4.6 Extraction recovery  
 
Recoveries were above 80 % for all the 2-, 3-, 4-isomers (Table 22) and above 50 % for the 
classical phenethylamines (Table 23). The recoveries for the 2-, 3-, 4-phenethylamines are 
generally high at both concentration levels. Recovery of the classical phenethylamines is 
lower with low concentration samples, but it is considered to be adequate as the interday and 
intraday precision and accuracy is satisfactory even at lower concentration levels. 
 Table 22. Data from extraction yield of the 2-, 3-, 4-isomers. 









              
2-fluoroamphetamine 0.25 µM 68 % 85 % 
  1.0 µM 76 % 95 % 
3-fluoroamphetamine 0.25 µM 69 % 87 % 
  1.0 µM 74 % 92 % 
4-fluoroamphetamine 0.25 µM 67 % 84 % 
  1.0 µM 67 % 84 % 
2-fluoromethamphetamine 0.24 µM 77 % 96 % 
  1.0 µM 64 % 80 % 
3-fluoromethamphetamine 0.28 µM 72 % 90 % 
  0.99 µM 78 % 98 % 
4-fluoromethamphetamine 0.27 µM 73 % 91 % 
  0.99 µM 78 % 98 % 
       
*Corrected recovery refers to the correction for 800 µL volume taken after LLE during sample preparation. Described in 
chapter 3.7.2 and in AppendixV, Table V a.  
 
  
 Table 23. Data from extraction yield experiment of the classical phenethylamines. 







Corrected recovery*  
% 
              
Amphetamine 0.27 µM 40 % 50 % 
  0.99 µM 68 % 84 % 
Methamphetamine 0.25 µM 57 % 71 % 
  1.0 µM 65 % 81 % 
MDMA 0.27 µM 48 % 60 % 
  0.98 µM 73 % 91 % 
       
*Corrected recovery refers to the correction for 800 µL volume taken after LLE during sample preparation. Described in 




4.4.7 Carry-over  
 
Analysis of concentrations up to 1 µM was performed without carry-over for most analytes, 
but analysis of 10 µM samples could produce false positives with concentrations around 
LOQ, especially for the fluoromethamphetamines. This carry-over could affect the 
identification and quantification of the subsequent/the following samples. After high 
concentrations, it should be considered to inject a blank sample or inject to parallels of the 
following sample. This may be considered for routine analysis, where high concentration 
values can be expected from autopsy and intoxication patients, by e.g. blanks being injected 
1-2 times after every real sample. 
Carry-over under analysis was examined by injection of three consecutive blanks after one 
injection of a high concentration sample. Calculated concentrations of the chromatograms for 
the blanks injected was given as in µM and as percentage carry-over of the calculated 
concentration of the high concentration sample (10 µM), given in Table 24 and 25. 
 
Table 24. Percentage carry-over for the 2-, 3-, 4-isomers. 
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Analyte 



















                        
2-fluoroamphetamine 0.049 0.44 % 0.015 0.13 % 0.0077 0.07 % 
                        
3-fluoroamphetamine 0.070 0.66 % 0.019 0.18 % 0.0073 0.06 % 
                        
4-fluoroamphetamine 0.087 0.82 % 0.031 0.29 % 0.017 0.16 % 
                        
2-fluoromethamphetamine 0.049 0.46 % 0.012 0.11 % 0.0053 0.05 % 
                        
3-fluormethamphetamine 0.050 0.47 % 0.012 0.11 % 0.0057 0.05 % 
                        
4-fluormethamphetamine 0.069 0.65 % 0.039 0.37 % 0.032 0.29 % 
                        






Table 25. Percentage carry-over for the classical phenethylamines. 
Carry-over                       
                      n=3 
Analyte 



















                        
Amphetamine 0.040 0.44 % 0.025 0.28 % 0.018 0.19 % 
                        
Methamphetamine 0.030 0.34 % 0.0079 0.09 % 0.0049 0.06 % 
                        
MDMA   0.043 0.50 % 0.011 0.12 % 0.0058 0.07 % 
                        




No interfering peaks were found for the MRM transitions of the analytes of this method when 
testing 25 common drugs of abuse (Appendix VII). However, due to human error very low 
therapeutic concentrations were tested. Although the resulting absence of interfering peaks 
could indicate high specificity, the experiment should be repeated at higher concentrations. 
The eight blank samples prepared from blank blood indicated no interfering endogenic 





5 Final remarks and future experiments 
 
This thesis work only scratches the surface of the possibilities and constraints of using SFC. 
Still there are questions left unanswered and effects left undiscovered as there are several 
experiments to do in order to further elaborate on these questions. Most challenges and 





Too high concentration of standards and controls lead to a non-linear standard curve. A 
second order curve fitted the standard curve somewhat better for concentrations up to 5-6 µM, 
as the highest concentrations lead to a possible saturation during ESI and thus it is probable 
that these concentrations are outside the linear area. 
 
5.2 Internal standards 
 
The 2-, 3-, 4-isomers where analysed with isotope-labelled PMMA. It would be interesting to 
also run the analysis and validation with isotope-labelled analogue ISs, in order to reduce 
variation due to ion suppression (Berg and Strand, 2011). 
 
5.3 Stability  
 
The stability of the samples where not tested. Analysis methods of similar compounds at 
NIPH indicates that the analytes tested in this thesis work might be stable over longer periods 
of time under different storage conditions. Still, differences in stability might exists and 





5.4 Evaluation of nitric acid as a keeper during extraction 
 
Adding a proton donor such as a strong acid proved to be necessary in order to avoid the 
escape of analyte during evaporation. The proton donor is often referred to as a “keeper”, due 
to its ability to keep the analyte in the vial by protonation making it less capable of escaping 
the vial during evaporation.  
The sample preparation was performed both with and without using the nitric acid as a 
keeper. Adding a small amount (10 µL) of 0.1 % nitric acid in methanol ensured escape of the 
somewhat volatile analytes. Without addition of nitric acid, much of the analytes evaporated 
and the samples were no longer suitable for analysis (data not shown).  
Nitric acid is an effective keeper; however it caused some clogging problems downstream of 
the MS splitter, especially in the capillary of the MS. This might be caused by out 
crystallization of nitric acid salts in the transition to atmospheric pressure. Adding other acids 
as keepers or different dilutions of nitric acid added should be further evaluated in order to 
avoid deterioration of the capillary of the MS. 
 
5.5 Evaluation of retention drift  
 
The deteriorating effect of basic methanol on the silica-based stationary phases could, as 
mentioned, be due to effects such as modifier adsorption or silyl ether formation. However, 
the distinction between these two was not made in this thesis work. Rather, the deteriorating 
effect has been observed and no experiments have been done to elaborate on how the 
deterioration occurs.  
 
5.6 Evaluation of sample solvents 
 
Only a few sample solvents were tested and all were quite polar solvents. It would be 
interesting to also test solvents with weaker eluotropic value to better match the super- or 
subcritical mobile phase mainly consisting of the apolar CO2.   
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5.7 Supercritical or subcritical conditions 
 
To determine if the experiments are performed under supercritical conditions or not is a 
difficult matter (Page et al., 1991). However, the conditions might be or close supercritical 
when a small amount of modifier is added (Saito, 2013). Considering that the mixtures used in 
SFC only are monophasic and homogeneous under supercritical conditions, it calls for further 
research. It would be especially interesting to investigate the precision and accuracy of 





6 Conclusion of the thesis 
 
New synthetic amphetamines are being synthesized at high speed to circumvent current 
legislation. These synthetic amphetamines are often methylated or halogenated versions of the 
originals. This produces a range of possible products of synthesis, giving 2-, 3- and 4- 
positional isomers. These isomers have been challenging to distinguish by the laboratory of 
forensic analysis at NIPH by LC-MS/SMS. These new synthetic amphetamines and 
constitutional isomers of these amphetamines call for new and improved analytical tools. The 
interest of SFC has been renewed lately due to new and improved instrumentation. 
Amphetamine and methamphetamine have been analysed by SFC, but no effort has yet been 
made on employing this method for separation of constitutional isomers of “designed” 
amphetamines.  
The utilization of UHPSFC-MS/MS proved to be a good tool for the detection and 
quantification of nine out of twelve of the constitutional isomers included in this thesis work. 
However, there were a few challenges to the method. Utilization of an aqueous NH3 mobile 
phase additive caused occasional problems of clogging and was substituted for a methanolic 
NH3 additive. By using a water-free mobile phase this clogging problem was reduced. 
However, over time the analytes which initially could be separated by UHPSFC experienced a 
retention time drift, peak broadening and reduced separation with the water-free mobile phase 
corresponding to the number of injections of the column. This degeneration of the column 
could be a result of modifier and/or NH3 adsorption to the silanol seats of the stationary phase, 
and could be partially reversed by washing the column with water. Furthermore, spray pulsing 
was occasionally observed. This problem occurred at the interface of the UHPSFC and the 
tandem MS, caused by the transition of the compressed CO2-dominated mobile phase to 
atmospheric pressure. As CO2 is only soluble with solvents in supercritical state, the transition 
of CO2 to gas phase separates the mobile phase into two phases of liquid and gas, causing a 
pulsating spray through the MS injection device. 
The 2-, 3-, 4-methylamphetamines were not separated by UHPSFC-MS/MS. The 2-, 3-, 4-
methylmethcathinones were initially successfully separated with UHPSFC, but their 
separation was irreversibly affected by the degradation of the column and could not be 
quantified over time. However, an UHPSFC-MS/MS method for analysis of 2-, 3-, 4-
fluoroamphetamines, 2-, 3-, 4-fluormethamphetamines, amphetamine, methamphetamine and 
MDMA was successfully developed and validated. However, the 2-, 3-, 4-
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methylamphetamines could not be successfully separated with UHPSFC, but could potentially 
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Appendix I Preparation of Standard, Control and Internal Standard Solutions 
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Appendix II Calculations of molar volumes  
 
Volume required to make 0.3 % NH3 250 mL prepared solution from a 25 % NH3 solution: 
            
    
    
  
  
    
          
   
  
        
 
Molar quantity of NH3 in 0.3 % NH3: 
Using 25 % aqueous NH3, with a density of 0.903 g/mL  
Volume of prepared solution: 250 mL 
Molar mass NH3: 17.031 g/mol 
 
Finding the volume of pure NH3 in the 0.3 % NH3 250 mL prepared solution: 
           
    
         
Finds the mass of this volume: 
       
            
 
  
           
Finds the mass of pure NH3 by correcting for using 25 % NH3: 
             
    
               
Finds the number of moles in the prepared solution: 




   
           
            
  
                     
Finds the molar concentration of NH3 in the prepared solution: 






   
                 
       
  
                    
        
The solution of 0.3 % aqueous NH3is equivalent to 40 mM NH3 prepared from NH3 dissolved in 
methanol. The molar concentrations of the 0.1, 0.2 and 0.4 % solutions are calculated in the same 
manner.  
 
The volume required to produce a 250 mL 40 mM NH3 in methanol solution from a 2 M NH3 in 
solution: 
            
    
    
  
  
    
            
  
  
        
The concentration of the 250 mL 40 mM NH3 in methanol solution produced from a 2 M NH3 in 
solution: 
 
            
    
    
  
  
    
      
     
  
          






Appendix III Name of the Field of Supercritical Fluid Chromatography 
 
Supercritical fluid is defined as an element or a compound above its critical pressure and 
critical temperature. It is a misleading name, which implies enhanced properties that in reality 
are unjustified. Initially, supercritical fluid chromatography was categorized as high-pressure 
or dense gas chromatography (HPGC or DGC) (Giddings et al. 1969; Saito, 2013). 
Supercritical fluid chromatography may not be a good name, as most of the present day 
analyses are performed in subcritical conditions due to addition of organic modifier. Jim 
Lovelock suggested the name “critical state chromatography” at a GC conference in 1957. In 
1962, Klesper called the technique “high pressure GC above critical temperatures”. This is not 
a good name, since it is not a GC technique, considering that the mobile phase acts like a 
solvent and is not inert. Giddings, probably the most influential chromatographic theorist in 
the 1960’s, used several names, including: turbulent flow chromatography, ultra high pressure 
gas chromatography (to 2000 atmospheres) and dense gas chromatography. However, none of 
these names captured the solvating nature of the technique. Sie and Rijnders first used the 
name supercritical fluid chromatography. This name is generally accepted/currently most 
used, but implies that the fluid must always be in a supercritical state, meaning above critical 
point to display the desirable characteristics, which also is not true. Caude was the first to use 
the term ‘subcritical’ to denote the fact that some modified CO2 based fluids were of high 
density, while still highly compressible, but acted as a solvent even below their critical 
temperature (Berger, 2014). So in fact, SFC is almost always carried out below supercritical 
conditions, in or below the subcritical area when the mobile phase contains significant 
concentration of an organic modifier or some other additive, which is most frequent in 
preparative applications due to the relatively low solubility of polar compounds in liquid CO2.  
The name supercritical fluid chromatography is thus often inadequate as the conditions often 
are below critical value for the mobile phase fluid. The term subcritical fluid chromatography 
is alternatively used, but is equally inadequate as a subcritical fluid (with P>Pc and T>Tc) is 
actually a liquid. The term “enhanced fluidity liquid chromatography” (EFLC) has also been 
used, mainly be the group of Susan Olesik, when adding CO2 to methanol/water mobile 
phases in RPLC (Cui and Olesik, 1995; Lee and Olesik, 1995). The purpose of using CO2 in 
EFLC is to reduce the fluid viscosity, thereby improving efficiency, and reducing the analyses 
duration both by the flow rate enhancements and the change of solvent strength. The increase 
in solutes diffusivity may be related to the ability of CO2 to break the hydrogen bonds 
132 
 
between methanol and water. It was also shown that isocratic elution EFLC compared 
favorably to gradient elution HPLC, allowing the separation of compounds with a large range 
of retention factors. 
The approach of EFLC differs from that of SFC in that the former consists of introducing a 
portion of CO2 (up to 50 %) into an aqueous liquid mobile phase, while the latter consists of 
introducing a portion of a liquid solvent (up to 50 %) into a CO2 supercritical fluid. The 
difference between the two is thus subtle or nonexistent. Consequently, EFLC and SFC can be 
considered as two ends of a unique method. A recent paper from the group of  Takeshi Bamba 
showed a gradient elution moving from 2 to 100 % modifier (methanol-water 95:5 with 0.2 % 
ammonium formate) to achieve the separation of water- and fat-soluble vitamins in a single 
run (Taguchi et al., 2014). This chromatogram really bridges the gap between SFC and 
HPLC, and may be representative of the future trends in operating SFC. 
More recently, the name “convergence chromatography” was proposed by Waters inc., to 
suggest the intermediate position of the mobile phase between gases and liquids. This idea 
was based on a comment from Giddings (1969), saying that “one of the most interesting 
features of ultra-high pressure gas chromatography would be the convergence with classical 
chromatography.” While it makes sense, it may be confusing to inexperienced 
chromatographers wondering what the difference between “convergence chromatography” 
and “SFC” is. Since no consensus has yet been reached, in the present thesis work, SFC is 
used as an acronym. SFC here defines a chromatography technique with CO2 in the mobile 





Appendix IV Prevalence 
 
In recent years, methamphetamines have experienced a larger increase in consumption 
relative to amphetamine. Bramness studied this increase and emphasized the unusual 
tendency in Norway in respect to the lack of user distinction between methamphetamine and 
amphetamine and attributed this to the fact that both amphetamine and methamphetamine are 
sold as white powder in Norway, while it is more often sold in its crystalline form in other 
countries. Bramness indicated that the perceived ability of some users to evaluate the purity of 
the drug could in fact be recognition of methamphetamine rather than amphetamine. Due to 
the lack of distinction between the two among users, amphetamine and methamphetamine are 
most often reported collectively as amphetamines in surveys in Norway (SIRUS - The drug 




Table IV a. Annual number of samples received at NIPH and %-positive detections. Data from the NIPH-report, 2014. 
 
Annual number of cases received at NIPH and %-positive detections  



































14377 40 % 
Driving under 

















5132 93 % 
Driving under 





































































1631 78 % 
Workplace drug 
testing 
1844 3 % 1736 2 % 1464 5 % 1508 4 % 1149 5 % 1540 4 % 
Impairment due 





































530 62 % 





































211 67 % 












7 25 % 
Annual number 


























Appendix V Evaluation of Extraction Agent  
 










Appendix VI Regeneration of the BEH-Column  
 
BEH columns were washed at different regimes, but the best results were obtained at a flow 
of 0.5 mL/min with H2O (Milli-Q water with 0.003 % formic acid) for 6 hours and then 1 





Appendix VII Complete Data Set of Method Validation 
Table VII a. Interday precision and accuracy 
   n=8 
  
   
  Concentration 
(µM) 
  Mean value 
(µM) 
  Accuracy 
(%) 
RSD (%) 
      
Analyte           
2-fluoroamphetamine 0.000   0.0025     -0.010   120         
  0.001   0.0024     140   75         
  0.005   0.0044     -12   32         
  0.010   0.0094     -6.2   24         
  0.100   0.11     9.3   8.2         
  1.004   1.1     7.8   8.5         
  5.022   5.4     7.4   7.4         
  10.04   10     1.8   8.3         
3-fluoroamphetamine 0.000   0.0024     -0.010   130         
  0.001   0.0033     230   61         
  0.005   0.0042     -17   35         
  0.010   0.010     0.61   22         
  0.101   0.11     5.7   16         
  1.005   1.2     16   6.4         
  5.027   5.7     12   12         
  10.05   10     4.4   7.1         
4-fluoroamphetamine 0.000   0.0051     0.01   110         
  0.001   0.0034     240   77         
  0.005   0.0046     -9.5   40         
  0.010   0.010     -4.5   46         
  0.101   0.11     13   14         
  1.012   1.1     13   6.6         
  5.061   5.6     11   12         
  10.12   9.8     -2.8   2.7         
2-fluoromethamphetamine 0.000   0.0025     -0.010   120         
  0.001   0.0023     130   55         
  0.005   0.0053     3.8   49         
  0.010   0.010     1.2   17         
  0.101   0.12     22   15         
  1.010   1.2     18   7.5         
  5.052   5.6     11   8.2         
  10.10   11     5.2   6.4         
3-fluoromethamphetamine 0.000   0.0048     -0.010   140         
  0.001   0.0049     390   120         
  0.005   0.0067     31   71         
  0.010   0.011     12   32         
  0.101   0.12     19   15         
  1.011   1.2     18   8.5         
  5.056   5.6     10   5.4         
  10.11   11     9.0   5.8         
4-fluoromethamphetamine 0.000   0.0079     -0.010   68         
  0.001   0.0087     770   66         
  0.005   0.012     140   44         
  0.010   0.014     45   30         
  0.101   0.11     12   8.9         
  1.009   1.1     11   6.1         
  5.046   5.2     3.1   12         




                          
Table VII b. Precision and accuracy 
  
  
Precision and accuracy measured in between series 
(n=8) 
  
    
  
Concentration (µM) 





      
Analyte           
                          
Amphetamine 0.000   0.0037     -0.010   64         
  0.005   0.0070     41   46         
  0.010   0.011     8.4   19         
  0.100   0.10     2.3   5.4         
  1.004   1.0     -0.76   9.2         
  5.022   5.0     -0.76   5.6         
  10.04   10     0.69   3.7         
                          
                          
Methamphetamine 0.000   0.0014     -0.010   130         
  0.005   0.0060     20   34         
  0.010   0.010     -2.1   13         
  0.101   0.10     2.2   5.4         
  1.005   1.1     9.1   17         
  5.027   5.1     2.3   5.1         
  10.05   10     3.1   3.5         
                          
MDMA 0.000   0.0026     -0.010   110         
  0.005   0.0074     45   50         
  0.010   0.010     -0.35   24         
  0.101   0.10     -0.91   6.5         
  1.012   1.0     -0.84   6.2         
  5.061   4.9     -2.2   5.6         








Table VII c. Intraday precision and accuracy 
Intraday precision and accuracy for the 2-, 3-, 4-
phenethylamines 








µM µM µM % % 
0.0050 0.0030 0.0034 113 61 
0.010 0.0082 0.0019 23 82 
0.10 0.11 0.015 14 110 
1.0 1.2 0.15 12 120 
5.0 6.1 0.51 8.3 121 
10 11 0.88 7.6 116 
  











µM µM µM % % 
0.0050 0.0045 0.0012 28 90 
0.010 0.0091 0.00085 9.4 91 
0.10 0.11 0.012 10 115 
1.0 1.2 0.073 5.9 123 
5.0 6.6 0.39 6 130 
10 11 0.63 5.3 118 
  









µM µM µM % % 
0.0051 0.0029 0.0010 35 57 
0.010 0.0078 0.00089 11 78 
0.10 0.12 0.0078 6.6 117 
1.0 1.29 0.056 4.3 127 
5.0 6.2 0.57 9.3 122 
10 11 0.62 5.8 106 
  
















µM µM µM % % 
0.0050 0.0072 0.0019 26 140 
0.010 0.012 0.0015 12.3 125 
0.10 0.13 0.0171 13.2 129 
1.0 1.2 0.074 6.1 121 
5.0 5.8 0.42 7.2 116 
10 11 0.57 5.1 111 
  










µM µM µM % % 
0.0050 0.0057 0.00073 13 112 
0.010 0.011 0.0013 12 111 
0.10 0.13 0.0034 2.6 131 
1.0 1.2 0.065 5.5 117 
5.0 5.9 0.34 5.7 117 
10 11 0.73 6.6 110 
  









µM µM µM % % 
0.0050 0.0225 0.0010 4.4 450 
0.010 0.029 0.0011 3.8 287 
0.10 0.13 0.0072 5.5 130 
1.0 1.2 0.06 5.2 116 
5.0 5.9 0.29 5.0 116 




Table VII d. Intraday precision and accuracy for the classical phenethylamines 
Intraday precision and accuracy for the classical 
phenethylamines  
  









µM µM µM % % 
0.0050 0.016 0.0057 35 330 
0.010 0.031 0.0085 28 308 
0.10 0.11 0.0063 5.8 106 
1.0 1 0.05 5 100 
5.0 4.9 0.18 3.7 98 
10 10 0.37 3.6 101 
  









µM µM µM % % 
0.0050 0.0060 0.0021 34 120 
0.010 0.0092 0.0013 14 92 
0.10 0.095 0.0055 5.8 95 
1.0 1.0 0.037 3.6 103 
5.0 5.1 0.14 2.7 101 
10 10 0.18 1.8 103 
  











µM µM µM % % 
0.0050 0.0071 0.0028 39 142 
0.010 0.0094 0.00053 5.7 94 
0.10 0.099 0.0024 2.4 99 
1.0 1.0 0.030 2.9 102 
5.0 5.0 0.099 1.5 100 







Linearity graphs of the 2-, 3-, 4-isomers: 
 




















































Table VII e. Table showing the drugs and their respective concentrations used in measuring specificity for the method. 
Substance  
Concentration 
(µM) 
Morphine 0.005625 
Codein 0.005625 
Ethylmorphine 0.0375 
Oxycodone 0.009375 
Fentanyl 0.0005625 
Amphetamine 0.028125 
Metamphetamine 0.028125 
MDMA 0.028125 
Tramadol 0.046875 
Zolpidem 0.009375 
Alprazolam 0.00425 
Flunitrazepam 0.0009375 
Klonazepam 0.00225 
Nitrazepam 0.009375 
Fenazepam 0.001875 
Bromazepam 0.009375 
Lorazepam 0.005625 
Buprenorfine 0.000475 
Diazepam 0.03125 
N-desmethyldiazepam 0.03125 
Midazolam 0.01625 
Oxazepam 0.15625 
Methadone 0.0225 
Meprobamate 0.625 
Carisoprodol 0.625 
 
  
 
 
61 
  
